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MULTIPLEX-PCR BASED SCREENING AND COMPUTATIONAL 
MODELING OF VIRULENCE FACTORS AND T CELL MEDIATED 
IMMUNITY IN HELICOBACTER PYLORI INFECTIONS FOR ACCURATE 
CLINICAL DIAGNOSIS 
SUMMARY 
Helicobacter pylori (H. pylori) is a gram-negative, microaerophilic, spiral-shaped 
bacterium that colonizes the stomach of more than half of the world’s population 
during their life span. The bacteria appear around 3μm in length and possess a 
unipolar bundle of two to six sheathed flagella, about 0,5μm in size, that enable the 
bacteria to move in the acidic environment of stomach. H. pylori infection is usually 
acquired in early childhood and persists throughout the life. While most infected 
individuals remain asymptomatic, H. pylori infection can cause peptic ulcer, chronic 
gastritis, mucosa-associated lymphoid tissue (MALT) lymphomas and gastric cancer 
in 20% of the infected ones. The prevalence of H. pylori is higher in developing 
countries and it may reach 70-80% of adults in Turkish population. While the exact 
route of transmission is unknown, acquisition may occur through fecal to oral or oral 
to oral contact. H. pylori infection can be diagnosed by the presence of dispeptic 
symptoms. Invasive and non-invasive methods are also used for the diagnosis of the 
H. pylori infection. Combination of antimicrobial agents and proton pump inhibitors 
has been used for the treatment of H. pylori infection; however, drug resistance may 
cause treatment failures, for which different drug combinations are used to overcome 
this problem. The outcome of H. pylori infection is closely related with bacteria's 
virulence factors, host genetic factors and host immune response. Bacterial virulence 
factors contribute to the inflammatory response towards H. pylori either by different 
mechanisms like host-signaling pathways, maintaining tissue homeostasis in 
epithelial cells or by stimulating the innate immune cells. Cytotoxin-associated gene 
A (cagA), vacuolating cytotoxin gene A (vacA), outer inflammatory protein A 
(OipA), blood group antigen-binding adhesion (BabA), putative neuraminyllactose-
binding hemaggluttinin homolog A (HpaA), neutrophil activating protein A (NapA), 
duodenal ulcer promoting gene A (dupA), urease subunit A (UreA), urease subunit B 
(UreB) are the most important H. pylori virulence factors that play a role in the 
bacterial adhesion, colonization and infection.  
Besides the virulence factors, type of the immune response of the host against H. 
pylori is crucial for the outcome of the infection. T cells are types of lymphocytes 
that play a central role in cell-mediated immunity against H. pylori infection. T cells 
develop in the thymus, and then enter the circulatory system. T cells are classified as 
cytotoxic T cells (CD8
+
 T cell), helper T cells (CD4
+
 T cell) and regulatory T cells 
(CD4
+
CD25
+
 T cell). Helper T cells differentiate into five major subsets known as T 
helper 1 (Th1), T helper 2 (Th2), T helper 17 (Th17), T helper 9 (Th9) and T helper 
22 (Th22). T helper 1-based immune responses are required for protection against 
intracellular pathogens. T helper 2 cells are responsible for the protection against 
extracellular parasites. Recently described T helper 17 (Th17) cells are responsible 
xx 
 
for mediating defensive mechanisms of the host against various infections including 
extracellular bacteria and fungi infections.  
In previous studies, the association between T cells and H. pylori infection has 
already been identified. Th1 and Th17 cells are involved in response to H. pylori 
infection and contribute to the development of H. pylori – related pathology. 
Moreover, colonization with H. pylori leads to the expansion of regulatory T cells 
(Tregs) which limits the inflammatory response and cause the establishment of 
chronic infection. Th1, Th17, and regulatory T-cells (Treg) are localized in both 
gastric mucosa and peripheral blood of H. pylori – infected patients.  
It is anticipated that there may be a close relationship between the H. pylori infection 
and bacterial virulence factors for the clinical outcomes of the infection. However, 
the effects of nine major Helicobacter pylori specific virulence factors; CagA, VacA, 
OipA, BabA, HpaA, NapA, DupA, UreA, UreB on Th1, Th17 and Treg cell response 
in H. pylori - infected patients with gastritis and ulcer have not been fully elucidated. 
Therefore in this study, we aimed to investigate the association between the nine 
major (CagA, VacA, OipA, BabA, HpaA, NapA, DupA, UreA, UreB) Helicobacter 
pylori specific virulence factors with three various T cell subsets (Th1, Th17 and 
Treg) at mRNA expression levels in H. pylori-infected gastritis and ulcer patients. 
The presence/absence of nine virulence factors were detected using multiplex-PCR 
and mRNA expression levels of T cell specific factors were determined using 
quantitative real time-PCR. 
In total of 80 adult patients, 18 with ulcer and 62 with gastritis were included in this 
study. In addition, 18 patients with reactive gastropathy were included as the 
negative control group. These patients were admitted to Acibadem hospitals with 
gastrointestinal symptoms and underwent endoscopy. During endoscopy, two gastric 
antral and corpus biopsies were taken from each patient. One antral and one corpus 
samples were used for DNA isolation and the other antral and corpus samples were 
used for RNA isolation. Isolated DNA samples were used to develop a multiplex-
PCR assay to detect nine H. pylori-specific virulence factor genes. Moreover, RNA 
samples were used to detect expression levels of Th1, Th17 and Treg cells - specific 
cytokines and transcription factors using quantitative real- time PCR (RT-PCR) 
assays. Primers were designed using primer design software for the H. pylori – 
specific virulence genes, Th1, Th17 and Treg cell – specific cytokines and 
transcription factors.  
First step of the study was the development of multiplex-PCR to detect virulence 
factor genes. Optimization of multiplex-PCR assay was done by using H. pylori G27 
strain that includes all the virulence genes. Also, a multiplex urease PCR assay was 
developed to detect ureA and ureB genes in a single PCR assay. In the second step, 
positive samples were detected by the conventional PCR for each cytokine and 
transcription factor. These positive samples were used to set up the standard curve in 
the quantitative real time-PCR for each cytokine and transcription factor. 
Detection of the nine virulence genes using a multiplex-PCR assay within a three 
polymerase chain reaction was achieved; ureA, ureB, cag A, hpaA, napA in a one 
reaction, oipA, dupA, vacA in another reaction and babA in a third reaction. All DNA 
isolated from biopsy samples were tested with the developed multiplex urease PCR 
assay. A comparison study was performed between the results of the multiplex 
urease PCR assay, rapid urease test and pathological evaluation that were applied to 
patient samples. According to the results, it was determined that multiplex urease 
xxi 
 
PCR and pathological evaluation methods produced more similar and precise results 
than the rapid urease test method. Within all virulence factors that were tested, only 
the prevalence of NapA virulence factor was significantly higher in patients with 
ulcer than gastritis. Additionally, a positive correlation between the H. pylori DupA 
virulence factor and IFN-γ, and H. pylori BabA virulence factor and IL-17 was 
detected in gastritis and ulcer patients, respectively. By using computer-based 
models, clinical outcomes of patients infected with H. pylori can be predicted by 
screening the patient's H.pylori vacA m1/m2, ureA and cagA status and IFN-γ (Th1), 
IL-17 (Th17), and FOXP3 (Treg) mRNA expression levels. Herein, for the first time, 
the relationship between H. pylori virulence factors and host immune responses for 
diagnostic prediction of gastric diseases using computer-based models were reported. 
Furthermore, a novel expert - derived model has been developed to identify the set of 
factors and rules that may distinguish the ulcer patients from gastritis patients.  
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HELICOBACTER PYLORI ENFEKSİYONLARININ DOĞRU KLİNİK 
TANISI İÇİN VİRULANS FAKTÖRLERİ İLE T HÜCREYE BAĞIMLI 
BAĞIŞIKLIĞIN ÇOKLU-PZT İLE TARANMASI VE BİYOİNFORMATİK 
MODELLEMESİ 
ÖZET 
Helicobacter pylori dünya nüfusunun yarısından fazlasında, yaşamlarının bir 
döneminde görülen kronik mide enfeksiyonlarına yol açan bir bakteridir. H. pylori 
gram negatif, mikroaerofilik, spiral şeklinde bir bakteridir ve yaklaşık olarak 3 
mikrometre uzunluğunda olup, 0.5 mikrometre çapında 2 ile 6 mikrometre arasında 
değişen hareket etmesine yardımcı olan kamçılara sahiptir. Çocukluk çağında 
kazanılan H. pylori enfeksiyonu ömür boyu sürmektedir. H. pylori ile enfekte olan 
bireylerin büyük çoğunluğu hastalık belirtisi göstermezken, bakterinin enfekte ettiği 
kişilerin % 20’sinde kronik gastrit, peptik ülser, mukoza ile ilişkili lenfoid doku 
lenfoması (MALT) ve mide adenokarsinomunda etiyolojik etken olduğu yönünde 
önemli bulgular vardır. Bakterinin prevalansı, gelişmekte olan ülkelerde gelişmiş 
ülkere kıyas ile daha yüksektir. Ülkemizde ise erişkin toplumun yaklaşık % 70-80 
kadarında bulunur. Bakterinin tam olarak bulaş yolu bilinmemekle beraber fekal-oral 
ya da oral-oral yollar ile bulaş olabildiği düşünülmektedir. H. pylori enfeksiyonunun 
tanısı genellikle dispeptik belirtilerin varlığı ve H. pylori enfeksiyonunu gösteren 
invaziv ve invaziv olmayan bazı testler yapılması sonucunda konur. Enfeksiyon 
tedavisi için kullanılan standart H. pylori antibiyotikleri ile proton pompası 
inhibitörlerinin yanı sıra son yıllarda hızla gelişen ilaç direnci H. pylori 
enfeksiyonunun tedavisi için farklı ilaç kombinasyonlarının uygulanmasını 
gerektirmiştir. 
H. pylori enfeksiyonu sonucu oluşabilecek klinik tablolar bakterinin virülans 
faktörleri, konağın genetik faktörleri ve bağışıklık yanıtı ile yakın ilişki içerisindedir. 
H. pylori’nin virülans faktörleri bakterinin neden olduğu yangıya, doğal bağışıklık 
hücrelerini uyarmak, epitel hücrelerindeki doku homeostazisini korumak ya da 
konağın sinyal yolakları etkilemek gibi farklı mekanizmalar yardımı ile yol 
açmaktadır. cagA (sitotoksinle ilişkili A geni), vacA (vaküol oluşturucu sitotoksin 
geni), babA (epitel hücrelerde fukosillenmiş Lewis B antijenlerine bağlanan adezin 
proteinini kodlayan gen), oipA (dış zar enflamatuar A proteinini kodlayan gen), hpaA 
(hücreye bağlanmayı güçlendiren, hücre saldırısını kontrol eden adezin genleri), ure 
A ve ureB  (üreaz enzimini kodlayan genler), dupA (duodenal ülser yönlendirici gen), 
napA (nötrofil aktive edici gen) H. pylori’nin mide mukozasına tutunmasında, 
kolonize olmasında ve mide de enfeksiyona neden olmasında etkili olan en önemli 
virülans faktörleridir. 
H. pylori’nin virülans faktörlerinin yanı sıra konağın H. pylori enfeksiyonuna karşı 
oluşturduğu bağışıklık yanıtı da enfeksiyonun doğuracağı klinik tablolar açısından 
oldukça önemlidir. T hücreleri, hücresel bağışıklık yanıtının parçası olup H. pylori 
enfeksiyonundan korunmada önemli göreve sahiptirler. Gelişimleri timusta 
gerçekleşir ve sonrasında periferdeki sekonder lenfoid organlara göç ederler. T 
hücreleri,  CD8+ sitotoksik T hücreleri, CD4+ yardımcı T hücreleri ve düzenleyici T 
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hücreleri (CD4+CD25+ Treg) olmak üzere üç gruba ayrılmaktadır. Yardımcı T 
hücreleri konağın gösterdiği bağışıklık yanıtında aracı hücrelerdir. Yardımcı T 
hücreleri T yardımcı 1 (Th1), T yardımcı 2 (Th2) ve T yardımcı 17 (Th17), T 
yardımcı 9 (Th9) ve T yardımcı 22 (Th22) olarak adlandırılan beş ayrı yardımcı T 
hücrelerine farklılaşmaktadır. Th1 hücreleri kaynaklı bağışıklık yanıtı hücre içi 
patojenlere karşı korumada rol almaktadır. Th2 hücreleri, hücre dışı parazitlere karşı 
oluşturulacak bağışıklık yanıtında görevlidir. Th1 ve Th2 hücrelerinden farklı olan ve 
yakın zaman önce tanımlanan Th17 hücreleri ise hücre dışı mikroorganizmalara karşı 
konak savunma mekanizmalarından sorumludur. Th9 hücrelerinin patolojik rolü çok 
açık olmamakla birlikte, pro-inflamatuar Th17 hücrelerinin yol açmış olduğu 
bağışıklık yanıtını arttırdığı ve T hücre toleransını aracı olarak kullanarak allograft 
reddini önleyebildiği gösterilmiştir. Th22 hücreleri mikrobiyal patojenlere karşı 
savunmada, doku onarımı ve doku yenilenmesinde rol almaktadır.  
Düzenleyici T hücrelerinin (Treg) temel görevi ise bağışıklık yanıtının kontrol 
altında tutulmasını sağlamaktır. Otoimmün yanıtların oluşmasının engellenmesinde 
ve enfeksiyon sonrasında patojen mikroorganizma temizliğinde de görev almaktadır. 
CD4
+
 T hücrelerinin polarize yanıtları, salgıladıkları sitokin profillerine göre farklılık 
göstermektedir.  
Daha önce yapılan bilimsel çalışmalarda T hücreleri ile Helikobakter pilori 
enfeksiyonu arasındaki ilişki açıkça ortaya konmuştur ve belirtilen T hücre 
yanıtlarının H. pylori’nin farklı suşlarının içerdiği virülans faktörlerine göre farklılık 
gösterebileceği öne sürülmüştür. Konağın vücut bağışıklık yanıtına bağlı olarak,  Th1 
ve Th17 yardımcı hücrelerini kapsayan CD4+ T hücreleri H. pylori ile enfekte olan 
hastalarda enflamatuvar yanıtta yer almaktadır ve CD4+CD25+ düzenleyici T 
hücrelerinin miktarı H. pylori ile enfekte olan hastaların mide mukozasında ve 
periferik kanınında yüksek oranda bulunmaktadır. Fakat H. pylori enfeksiyonunda 
önemli rolü olan 9 virülans faktörünün; CagA, VacA, OipA, BabA, HpaA, NapA, 
DupA, UreA, UreB H. pylori ile enfekte olan hastarda görülen T hücre yanıtı ile 
(Th1, Th17 ve Treg) arasındaki ilişkileri tam olarak bilinmemektedir. 
Gerçekleştirdiğimiz çalışmamızda, H. pylori enfeksiyonunda önemli olduğu 
düşünülen dokuz virülans faktörü için geliştirilecek olan çoklu-PZT’nin sonuçları ile 
H. pylori ile enfekte gastritli ve ülserli hastalarda gelişen T hücre yanıtlarının, Th1, 
Th17ve Treg, arasındaki ilişkinin belirlenmesi amaçlanmıştır.  
Çalışmaya 1 yıl boyunca Acıbadem Hastaneleri Gastroenteroloji Servisi’ne dispepsi 
yakınmasıyla başvuran ve Endoskopi bölümünde gastroduodenoskopi uygulanan - 
18-65 yaş arası, çalışma kriterlerine uygun 18 ülserli, 62 gastritli toplam 80 erişkin 
hasta dahil edilmiştir. Negatif kontrol olarak ise18 reaktif gastropati tanısı konulan 
hasta kullanılmıştırdı. Endoskopi yapılan hastalardan antrum küçük kurvaturdan 2 
adet, korpus büyük kurvaturdan 2 adet olmak üzere toplamda 4 adet biyopsi örneği 
alınmıştır. Alınan biyopsi örneklerinin birinden DNA, diğerinden ise RNA 
izolasyonu yapılmıştır. İzole edilen DNA örnekleri dokuz farklı virülans genini bir 
arada saptayabilmek için geliştirilmek istenen çoklu-PZT çalışmaları için 
kullanılmıştır. RNA örnekleri ise T hücre alt gruplarının belirteçleri olan 
transkripsiyon faktörleri ve sitokinlerin RNA düzeyinde ekspresyonlarının 
incelenmesi için kullanılmıştır.  Virülans faktörleri ve Th1, Th17 ve Treg hücrelerine 
ait sitokinler ve transkripsiyon faktörlerini belirleyebilmek için primerler 
tasarlanmıştır. Çalışmaya virülans faktörlerini bir arada saptayabilmek için 
geliştirilmek istenen çoklu-PZT ile başlanılmış, H. pylori’ye ait olan tüm virülans 
faktörlerini taşıdığı bilinen G27 suşu pozitif kontrol olarak kullanılarak çoklu PZT 
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için tepkime denemeleri ve optimizasyon çalışmaları yapılmıştır. Ayrıca sadece ureA 
ve ureB genlerini tek bir PZT ile saptayabilen bir yöntemde geliştirilmiştir. T hücre 
alt gruplarının belirteçleri olan transkripsiyon faktörleri ve sitokinler için 
konvansiyonel PZT ile izlenebilir PZT’de standart eğriyi belirleyebilmek için pozitif 
hasta grupları bulunmuş ve optimizasyon çalışmaları tamamlanmıştır.  Optimize 
edilmiş izlenebilir PZT ile içerisinde 62 gastritli ve 18 ülserli hasta grubunun 
bulunduğu 80 hasta için Th1, Th17 ve Treg hücrelerinin gruplarının belirteçleri olan 
transkripsiyon faktörleri (RORɣT, FOXP3) ve sitokinlerin (IFNɣ, IL-17) RNA 
düzeyinde ekspresyonları izlenebilir PZT ile incelenmiştir.  
Çoklu-PZT optimizasyon çalışmaları sonucunda 9 farklı virülans genini üç farklı 
PZT karışımı ile saptamak olanaklı hale gelmiştir. ureA, ureB, cag A, hpaA, napA 
genlerinin bir karışımda, oipA, dupA, vacA genlerini bir karışımda ve babA genini bir 
karışımda saptamak olanaklı olmuştur. Çalışma sırasında geliştirilen yalnızca ureA 
ve ureB genini içeren çoklu bir PZT tepkimesi ile çalışma grubundaki hastalara üreaz 
taraması yapılmıştır. Geliştirilen çoklu üreaz PZT sonuçları ile hasta örneklerine 
uygulanan hızlı üreaz testi ve patolojik değerlendirme sonuçları arasında 
karşılaştırma çalışması yapılmıştır. Karşılaştırma çalışmaları sonuçlarına göre çoklu 
üreaz PZT ve patolojik değerlendirme yöntemlerinin hızlı üreaz test yöntemine göre 
daha benzer ve duyarlı sonuçlar verdiği belirlenmiştir. Çoklu-PZT sonuçları ve 
gerçek zamanlı-PZT sonuçları biyoinformatik çalışmalar ile bir araya getirilerek H. 
pylori enfeksiyonu sonucunda oluşabilecek gastrit ya da ülseri birbirinden 
ayırabilecek faktörleri birarada gösteren bilgisayar tabanlı modeller oluşturulmuştur. 
Çoklu-PZT sonuçlarına göre test edilen bütün virülans faktörleri içerisinde napA geni 
ülserli hastalarda gastritli hastalara göre daha yüksek oranda pozitif bulunmuştur. 
Ülserli ve gastritli hastalarda DupA virülans faktörü ile IFN-γ arasında, babA 
virülans faktörü ile IL-17 arasında pozitif ilişki bulunmuştur. Bilgisayar tabanlı 
modelleri doğrultusunda hastalardan izole edilen H. pylori’nin vacA m1/m2, ureA ve 
cagA gen durumlarının, enfekte olan hastaların IFN-γ (Th1), IL-17 (Th17) ve FOXP3 
(Treg) ekspresyon seviyelerinin bilinmesi ile enfeksiyonun doğuracağı klinik 
sonuçları önceden tahmin etmek olanaklı hale gelmiştir. Yapılan bu çalışmada H. 
pylori’ ye ait olan 9 virülans faktörü ile Th1, Th17 ve Treg hücre yanıtları arasındaki 
ilişki gastritli ve ülserli hastalarda açıkça ortaya konmuştur. Bu çalışma ile literatürde 
bilindiği üzere ilk defa H. pylori ile enfekte olan hastalardan izole edilen bakteri 
izolatlarının sahip olduğu virülans faktörleri ile hastaların bağışıklık yanıtı 
ilişkilendirilerek bilgisayar bazlı modeller kullanarak klinik sonuçlarını önceden 
tahmin etmek olanaklı hale gelmiştir. 
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1. INTRODUCTION 
1.1 Human Stomach 
Helicobacter pylori (H. pylori) has its ecological niche in the human stomach which is a 
thick- walled muscular organ that lies between the esophagus and the first part of the 
small intestine. Together with the digestive process function, human stomach eliminates 
the invasion of microorganisms because of its highly acidic environment where pH 
range changes between 1 and 2, due to the gastric acid production. In addition, the entire 
epithelial surface of the human stomach is covered with a thick layer of secreted mucus 
that acts as a physical barrier to prevent pathogens from colonizing and interacting with 
the underlying epithelium (Figure 1.1).  
However, H. pylori is able to colonize in the acidic environment of stomach by 
overcoming the thick mucus barrier. Urease enzyme production and motility function of 
H. pylori are two essential factors that play role in colonization inside the human 
stomach (Sherwood, 1997). 
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Figure 1.1 : Structure of human stomach (adapted from Cancer Information and Support 
Network [CISN], 2013). 
1.2 Microbiology of H. pylori 
1.2.1 Morphology 
H. pylori is a gram negative, spiral - shaped bacterium, approximately 3.5 μm in length 
and a diameter of about 0.5 μm. It is motile normally with a unipolar bundle of two to 
six sheathed flagella (about 3 μm long) which enable the bacteria to move in mucous 
layer of the gastric epithelium (Figure 1.2) (Doig et al., 1995). Each flagellum has a 
flagellar sheath as an extension of the outer membrane that protects the acid-labile 
flagellar structure from the attack of the stomach acid (Hawtin et al., 1990). 
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Figure 1.2 : Image of H. pylori, 10,000x computer- aided design, shows curved shape 
and flagella of the bacterium that enable the bacterium to propel  
itself into the mucus lining of the stomach ( adapted from The Helicobacter 
Foundation, 2015). 
1.2.2 Cellular envelope 
H. pylori has a unique outer membrane structure. The peptidoglycan layer of H. pylori 
contains a high amount of muropeptides, with a pentapeptide side chain ending in 
glycine and containing (1–6)-anhydro-N-acetylmuramic acid (Costa et al., 1999). 
1.2.3 Respiration and metabolism 
H. pylori is a microaerophilic bacterium that requires oxygen, but at a lower 
concentration than found in the atmosphere. H. pylori is a slow growing microorganism 
that can be cultured on solid media including blood or selective media like brucella agar 
supplemented with 5% horse blood, or brain heart infusion media with 7 % horse blood 
incubated at 37ºC for 3 to 7 days under 5% to 10% oxygen and 5% to 12% carbon 
dioxide with humidity conditions (Goodwin & Worsley, 1993). 
H. pylori produces oxidase, catalase, and urease enzymes that facilitate biochemical 
diagnosis of bacteria (Stark et al., 1999). Urease enzyme is vital for bacterial survival 
and colonization in the acidic stomach environment. In addition, bacterium contains a 
hydrogenase, which can be used to obtain energy by oxidizing molecular hydrogen (H2) 
produced by intestinal bacteria (Olson & Maier, 2002). H. pylori species are capable of 
forming biofilms (Stark et al., 1999). When the environment is not suitable for its 
survival it can convert from spiral to viable but nonculturable coccoid form. 
1.2.4 Microscopic features 
Under the microscope, it is possible to detect H. pylori that is stained by gram stain, 
giemsa stain, haematoxylin-eosin stain, Warthin-Starry silver stain and acridine-orange 
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stain. When the bacteria are stained with the gram staining it appears as gram-negative 
rods (Bode et al., 1993). 
1.3 History of H. pylori Infection 
Over 100 years ago, a Polish Clinical Researcher Prof. W. Jawroski at the Krakow 
Jagiellonian University described spiral shaped microorganisms in the human stomach. 
In the late 1970s Robin Warren, a Pathologist in Perth, noticed these bacteria on the 
inflamed gastric mucosa. He wondered whether there was a relationship between the 
inflammation and these bacteria. Then he learned that European pathologists had found 
similar microorganisms in the late 19th century, but they were not able to grow them in 
culture (Marshall & Warren, 1984). Barry Marshall, a young trainee in internal 
medicine, started to work with Warren on his observations. However, initially they had 
also difficulties culturing these unknown bacteria. They thought this curved shaped 
gram-negative bacteria from the biopsy samples were Campylobacter species, which 
cultured on selective media under microaerobic conditions within 48 hours. They began 
with 30 patients, but they did not achieve cultivation of the microorganism isolated from 
biopsy samples. Then, the Easter Holidays arrived; accidentally one of the cultures was 
incubated 5 days instead of the usual 2 days in the hospital laboratory and colonies were 
seen on this culture plate. Microorganisms isolated from the patients were called as 
Campylobacter like organisms (CLO) then in a short period of time Campylobacter 
pyloridis and Campylobacter pylori because of their similarity to the Campylobacter 
genus. Later, based on the differences between the newly isolated bacterium and 
Campylobacter, new bacterium was called as Helicobacter pylori (H. pylori) (Marshall 
& Warren, 1984). In 1985, Barry Marshall swallowed H. pylori to prove that it causes 
ulcer. However, instead of developing ulcer symptoms, he developed gastritis 
symptoms. In this way, Barry Marshall proved that Helicobacter pylori caused gastritis. 
At this time, it had become clear that H. pylori infection was strongly associated with 
gastric mucosa inflammation. Later connection between H. pylori and ulcer was 
eventually deduced from epidemiological studies that showed an increased incidence of 
ulcers in persons infected with the bacteria.  
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After Warren and Marshall’s publication, other investigators were able to culture the 
bacteria from their patients with gastritis and ulcer. In 1994, National Institutes of Health 
in America concluded that H. pylori was a major cause of peptic ulcer diseases as noted 
earlier by Marshall and Warren. In 2005, Warren and Marshall were awarded the Nobel 
Prize for their work on H. pylori (Kirsner et al.,1994). 
1.4 Epidemiology of H. pylori Infection 
Over the last few decades, the epidemiology of H. pylori infection has been changing in 
most countries with a decline of the prevalence of the infection. Changes have been 
confederate with a paralel decline in peptic ulcer disease, gastric cancer and other related 
diseases as gastroesophageal reflux disease, allergies and asthma. However, it has been 
shown in several studies that the prevalence of H. pylori is still high in most countries. 
In north European and North American populations, about one-third of adults are still 
infected with this pathogen, whereas in south and east Europe, South America, and Asia, 
the prevalence of H. pylori infection is frequently higher than 50% (Eusebi et al., 2014; 
Sonnenberg, 2013). 
1.4.1 Prevalence of H. pylori infection 
The global prevalence of H. pylori infection is more than 50%. In developing countries 
the prevalence is higher than in the developed countries (Table 1.1 and 1.2). The 
prevalence of H. pylori infection is closely related with age, ethnicity, gender, 
geography and socioeconomic status (Sonnenberg, 2013). 
In Europe, the prevalence of H. pylori infection appears to be lower in Northern 
countries than in Eastern and Southern countries (van Blankenstein et al., 2013). In 
South-Western Europe, Portugal, the prevalence reaches to 84.2 %. Turkey has the 
highest prevalence of H. pylori infection among the eastern European countries 
(Ozaydin et al., 2013). In North America, the prevalence of H.pylori seems to be similar 
to northern Europe (Sethi et al., 2013). In Asia, prevalence of H. pylori infection 
changes from 28.3 % to 86 %. Nigeria has the highest prevalence rate between the 
countries of Africa (Fock & Ang, 2010). 
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The prevalence of H. pylori infection in children is shown in Table 1.2. In Portugal the 
prevalence rate is 66.2%. In Brazil prevalence rate is 41.1% among children and young 
adults aged between 2 and 19 years old. Higher rate of infection was reported in Iran, 
where the prevalence is 50.5% (Ghasemi-Kebria et al., 2013). 
Table 1.1 : Prevalence of H. pylori infection in adults reported by studies published in 
2013 (Eusebi et al., 2014). 
Country 
(Reference) 
Setting Number 
Diagnostic 
Method 
Prevelance of 
Helicobacter 
pylori % 
References 
Western Europe 
The Netherlands Blood donors 1550 Serology 31.7 (van Blankenstein et al., 2013) 
The Netherlands Pregnant women 6837 Serology 46 (den Hollander et al., 2013) 
Portugal General population 2067 Serology 84.2 (Bastos, Peleteiro, Barros, et al., 2013) 
Eastern Europe      
Cyprus Patients with dyspepsia 103 PCR 39.8 
(Krashias, Bashiardes, Potamitou, 
Potamitis, & Christodoulou, 2013) 
Turkey General population 4622 UBT 82.5 (Ozaydin et al., 2013) 
America      
Canada Aborginal population 203 Histology 37.9 (Sethi et al., 2013) 
Mexico Pregnant women 343 Serology 52.2 (Alvarado-Esquivel, 2013) 
Asia      
Saudi Arabia Healty individuals 456 Serology 28.3 (Sethi et al., 2013) 
Korea Routine health check-up 10796 Serology 54.4 (Fock & Ang, 2010) 
India Patients with dyspepsia 2000 
Histology 
RUT 
58 (Sodhi et al., 2013) 
India Patients with dyspepsia 530 
Histology 
Urease Test 
62 (Adlekha S, 2013) 
China Healty individuals 5417 UBT 63.4 (Y. Zhu, Zhou, Wu, Su, & Zhang, 2014) 
Bhutan Volunteers 372 
Histology 
RUT 
Culture 
Serology 
73.4 (Vilaichone et al., 2013) 
Bhutun Patients with dyspepsia 244 Serology 86 (Dorji et al., 2014) 
Kazakhstan 
Asymptomatic and 
patients with dyspepsias 
835 Serology 76.5 (Benberin, 2013) 
Africa      
Ethiopa Selected population 1388 Serology 65.7 (Mathewos, 2013) 
Morocca Patients with dyspepsia 429 
Histology 
RUT 
Culture 
75.5 (Benajah, 2013) 
Nigeria Patients with dyspepsia 125 
Serology 
Histology 
93.6 
80 
(Benajah, 2013) 
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Table 1.2 : Prevalence of H. pylori infection in children reported by studies published in 
2013 (Eusebi et al., 2014). 
Country 
(Reference) 
Age of 
included 
subjects 
Number 
Diagnostic 
method 
Prevelance of 
Helicobacter 
pylori % 
References 
Western Europe 
Belgium 12-25 516 UBT 11 
(Olokoba, Gashau, Bwala, Adamu, & 
Salawu, 2013) 
Portugal 13 1312 Serology 66.2 (Bastos, Peleteiro, Pinto, et al., 2013) 
America      
Brazil 2-19 129 
Histology 
RUT 
Culture 
41.1 (Bastos, Peleteiro, Pinto, et al., 2013) 
Asia      
China 1-18 1634 
Histology 
RUT 
32.1 (Yu, Su, Wang, Wang, & Xu, 2014) 
Iran 1-15 194 Serology 50.5 (Ghasemi-Kebria et al., 2013) 
1.4.2 Risk factors for H. pylori infection  
Risk factors for H. pylori infection appears to be during childhood and early adult years 
(Gersten & Wilmoth, 2002). The vast majority of infections are asymptomatic, but 
infected individuals often have histological evidence of gastritis. Household hygiene, 
socioeconomic status, occupation, family income level, living conditions, cultural 
background and genetic factors are mainly focused risk factors for H. pylori infection. 
Individuals with lower education have higher risk than individuals with higher 
education. Also, the parent’s education level is one of the determinants as parents with 
higher education have lower risk for the H. pylori infection. Although no significant 
association has been found between the lifestyle habits, smoking, dietary, alcohol 
drinking, gender, age, and infection, these factors may be supposed as risk factors for H. 
pylori infection (Dorji et al., 2014; Hanafi & Mohamed, 2013; Vilaichone et al., 2013). 
1.4.3 Transmission 
The mode of transmission of H. pylori infection remains poorly understood. Although 
person-to-person transmission is accepted as the main route, there are many other 
transmission routes (Akamatsu et al., 1996). Iatrogenic transmission occurs when the 
same tubes or endoscopes are used for different patients during endoscopy (Lin et al., 
1994). Consumption of faeces contaminated water or foods are examples for the fecal to 
oral transmission route. The use of the same spoon by both mother and child is one of 
the causes for the oral-to-oral transmission route of H. pylori infection (Megraud, 1995). 
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1.4.4 H. pylori recurrence after eradication treatment 
Recurrence of H. pylori infection after successful eradication treatment is rare in 
developed countries and more frequent in developing countries (Gisbert, 2005). 
Recurrence is defined as recolonization of the same strain rather than a new strain that is 
defined as reinfection. As a clinical problem, recrudescence develops as a result of the 
treatment failure. Recrudescence rate is very high during the first year of treatment, then 
this rate decreases. However, reinfection risk is high for the treated patients during their 
lifespan. For H. pylori infection accurate diagnosis is difficult and most diagnoses rely 
on molecular methods which confirm that the identified bacteria are genetically identical 
(Peitz et al., 1999; Xia et al., 1997). High H. pylori recurrence rate has been seen in 
areas with low socioeconomic development because of the failure in treatment. 
1.5 H. pylori Associated Diseases 
Since the initial report about H. pylori by Marshall and Warren, it remains one of the 
most common human infections which are associated with a number of important upper 
gastrointestinal (GI) diseases including chronic gastritis, peptic ulcer disease, gastric 
cancer, and mucosa-associated lymphoid tissue lymphoma. 
1.5.1 Gastritis 
Gastritis is defined as the inflammation of the stomach in which peptic ulcer and gastric 
cancer may develop (Moller et al., 1994). The relationship between gastritis and H. 
pylori infection can be defined as the adhesion of H. pylori to the stomach lining and 
colonization inhibit the secretory functions of the mucus lining of the stomach and 
indicate a potential deleterious effect on this primary defense mechanism of the gastric 
mucosa. A sudden and severe stomach inflammation is called as acute gastritis. When 
inflammation endures for a long time that is called chronic gastritis. Erosive gastritis is 
another type of gastritis that often does not cause significant inflammation but can erode 
the stomach lining (Dixon, 2001). 
1.5.2 Peptic ulcer 
Peptic ulcer is a defect in the gastrointestinal mucosa when protective factors are 
weakened or the mucosa is exposed to large amounts of aggressive luminal factors, such 
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as acid and pepsin. One of the main causes of peptic ulcer is H. pylori infection. 
Colonization of H. pylori leads to increase in releasing level of gastrin and higher 
amount of gastrin promotes increase in acid secretion which damages intestinal lining 
causing peptic ulcer. Nonsteroidal anti-inflammatory drugs (NSAIDs) and 
acetylsalicylic acid (ASA) drugs are accepted as cause of at least 25% of the peptic 
ulcers (Bao et al., 2010; Wu et al., 2009). 
1.5.3 Gastric cancer 
In 2012, approximately 1 million cases of gastric cancer are diagnosed in the world 
(952,000 cases, 6.8% of the total) making the gastric cancer fifth most common 
malignancy. Gastric cancer is the third leading cause of death in cancer for both sexes’ 
worldwide (723,000 deaths which make up 8.8% of the total) (IARC, 2012). 
The World Health Organisation’s Agency Research for Cancer defined the H. pylori as a 
carcinogen in 1994 (Moller et al., 1994). H. pylori infection is the main cause of gastric 
cancer. In addition to H. pylori infection and accompanied inflammatory response there 
are other risk factors for gastric cancer such as host gene polymorphisms and dietary 
factors like high salted diet, older age, gender, tobacco smoking, a history of stomach 
surgery for benign conditions, and a family history of stomach cancer (Marshall et al., 
1985). 
Diffuse-type gastric cancer and intestinal-type adenocarcinoma are two distinct variants 
of gastric carcinoma. Diffuse-type gastric cancer is defined as infiltration of neoplastic 
cells that do not form glandular structures. Intestinal-type adenocarcinoma is defined as 
the transition from normal mucosa to chronic superficial gastritis followed by atrophic 
gastritis and intestinal metaplasia resulting with dysplasia and adenocarcinoma (Correa, 
1996; Sipponen & Marshall, 2000). 
Mucosa-associated lymphoid tissue (MALT) lymphoma is another cancer type 
associated with chronic H. pylori inflammation. Untreated H. pylori infection causes 
inflammation of the stomach lining and over time, this may lead to MALT lymphoma 
development (Parsonnet et al., 1994). 
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1.6 Pathogenesis of H. pylori Infection 
The pathogenesis of H. pylori infection in humans begins with entry; adherence and 
colonization of the bacteria to human gastric mucosa then continue with avoidance, 
subversion, or exploitation of the bacteria from the human immune system. This lasts 
with multiplication, tissue damage, and transmission to a new susceptible host or spread 
to adjacent tissue. Mainly, persistance and pathogenesis of H. pylori in the human 
stomach depends on its colonization on the gastric mucus layer and bacterial virulence 
factors which play important role in the progress of infection. 
1.6.1 H. pylori colonization 
The colonization of the H. pylori on the gastric mucus layer is the basis for 
pathogenecity and virulence (Figure 1.3). Motility is the first crucial step in the 
colonization of H. pylori. Flagella are essential for the motility of H. pylori and are 
important for the early stage of infection. H. pylori presents a typical bulb-like structure 
at its distal end that corresponds a dilation of the flagellar sheath. The sheath of flagella 
is an extension of the bacterial outer membrane and it protects the acid-labile flagellar 
structure from the attack of the gastric acid (Geis et al., 1993). 
There are three structural elements of the H. pylori flagella: a basal body that is 
embedded in the cell wall and comprises the proteins needed for rotation and 
chemotaxis; an external helically shaped filament that works like a propeller when 
rotated at its base; and a hook that attends as a joint between the flagellar filament and 
the basal body. Approximately there are more than 50 putative proteins that are involved 
in expression, secretion, and assembly of flagellar apparatus (Alm et al., 1999; Tomb et 
al., 1997). FlaA and FlaB are two flagellar proteins that play a role in the full motility of 
bacteria. FlgE and FliD are hook-associated proteins that are also essential for the 
motility and colonization (O'Toole et al., 1994). 
The second crucial step in the colonization is urease enzyme production of H. pylori. By 
the help of the urease enzyme bacteria can live in the acidic conditions of the gastric 
lumen. In the absence of urea, H. pylori can survive at a pH range between 4.0 and 8.0. 
However, urea helps H. pylori to survive at pH lower than 2.5. Urease enzyme catalyses 
the hydrolysis of urea to carbon dioxide (CO2) and ammonia (NH3). Production of NH3, 
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which acts as an acceptor for the H
+
 ions, leads to increase of local pH of the stomach 
environment where H. pylori can colonize. In addition, the production of NH3 may 
facilitate the formation of NH3-derived compounds, such as monochloramine, which has 
cytotoxic effects on host cells (Suzuki et al., 1992). Urease production of H. pylori 
allows short-term survival in the highly acidic evironment of gastric lumen, whereas 
motility allows rapid movement toward the more neutral pH zone of the gastric mucosa 
(Nakamura et al., 1998). 
Adherence is the third crucial factor for H. pylori colonization in the human stomach. 
Adhesion to the gastric epithelium prevents the bacteria being eliminated from the 
stomach by mucus turnover and gastric peristalsis. In addition, it helps to deliver 
bacterial effector proteins such as CagA and VacA to the host cell and has an important 
role in the nutrient uptake of bacteria from the host cells, which were damaged by the 
inflammation. Better adherence means better colonization in the host gastric epithelium. 
H. pylori expresses different adhesins that bind to specific host-cell receptors, to 
facilitate adherence on host tissue surface (Testerman et al., 2001). 
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Figure 1.3 : The colonization of the H. pylori on the gastric mucus layer; (1) H. pylori 
penetrate the mucus layer of host stomach and adhere the surface of gastric 
mucosal epithelial cells, (2) produce ammonia from urea by the urease, 
and the ammonia neutralizes the gastric acid to escape from elimination, 
(3) proliferate, migrate, and finally form the infectious focus, (4) the 
gastric ulceration is developed by destruction of mucosa, inflammation and 
mucosal cell death (adapted from BioWeb.edu.tr, 2016). 
1.6.2 Virulence factors of H. pylori 
Virulence factors are important for understanding the relationship between the bacterial 
phenotype with specific manifestations of disease and elucidating mechanisms of 
pathogenesis. Virulent strains are accepted to be more aggressive and increase the risk of 
developing H. pylori related gastric diseases.Virulence factors with potential predictive 
value for specific pathologies include; VacA, CagA, OipA, HpaA, DupA, NapA, BabA, 
UreA, and UreB. 
1.6.2.1 Vacuolating cytotoxin gene A (vacA) 
Vacuolating cytotoxin A (VacA) is one of the most extensively studied toxins produced 
by H. pylori. Approximately 50% of H. pylori strains secrete this highly immunogenic 
95-kDa protein. In addition to the induction of vacuolation, as named with reference to 
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form “vacuole-like’’ membrane vesicles in the cytoplasm of gastric cells, vacA has 
variety of effects on target cells, including colonization of H. pylori, cytochrome c 
release from mitochondria leading to apoptosis, disruption of mitochondrial functions, 
and binding to cell membrane which is followed by the initiation of a proinflammatory 
response, blockade of T-cell proliferation. Membrane channel formation, disruption of 
endosomal and lysosomal activity, effects of integrin receptor-induced cell signaling, 
interference with cytoskeleton-dependent cell functions, induction of apoptosis, and 
immune modulation are other activities of the VacA protein (Cover & Blanke, 2005).  
The vacuolating cytotoxin gene A (vacA) is possesed by approximately 50 % of H. 
pylori strains, but the sequence heterogenecity within the vacA gene causes vacuolating 
activities among strains. There are two divergent regions: The signal region (s) and the 
middle region (m). Signal region has been grouped into three different types; s1a, s1b 
and s2 (Figure 1.4). The middle region, which contains the p58 cell binding domain, has 
been grouped into m1 and m2 (van Doorn et al., 1998). Vacuolating activity is high in 
s1/m1 genotypes, intermediate in s1/m2 genotypes, and absent in s2/m2 genotypes 
(Atherton et al., 1995). The intermediate region (i) region between the s and m region, 
has been identified in 2007. All s1/m1 strains were classified as i1 type, s2/m2 strains 
were classified as i2 type (Rhead et al., 2007). Recently, d region, between the i and m 
regions has been identified. The d region is divided into d1 without deletion and d2 with 
a 69 to 81 bp deletion (Ogiwara et al., 2009).  
 
 
 
 
Figure 1.4 : Mosaic structure of the vacA gene; Three variable regions in the vacA gene 
sequence are the signal region (s region), mid- region (m region) and 
intermediate region (i region). There are two types of allelic variations in 
the s region and m region as s1, s2 and m1, m2. i1, i2 and i3 are the allelic 
variations in the intermediate region. 
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1.6.2.2 Cytotoxin- associated gene A (cagA)  
Pathogenecity islands (PAIs) are horizontally acquired genetic elements that contain 
virulence genes. The cytotoxin associated gene (cag) PAI of H. pylori encodes a type IV 
secretory system that allows the translocation of effector molecules, such as CagA 
virulence factor, into the host cell (Covacci & Rappuoli, 2000). The cag-PAI is 40 kb in 
size and encodes approximately 30 genes which are multicistronic and involved in the 
biogenesis of type IV secretion system (Censini et al., 1996). Moreover, expression of 
the genes within the cag PAI determines the differences in the ability of H. pylori strains 
to trigger chemokines from gastric mucosa (Atherton, 2000). Following H. pylori 
adherence to host cells, CagA is injected from bacterium into the bacterium-attached 
gastric epithelial cells and subsequent tyrosine phosphorylation by Src family kinases 
within epithelial cell where CagA functions as a scaffolding adaptor and interacts with at 
least ten host proteins that regulate cell growth, motility, polarity and intracellular signal 
transduction (Hatakeyama & Higashi, 2005). 
CagA virulence factor is translocated into gastric epithelial cells. After translocation it 
localizes to the inner surface of the plasma membrane, in which it undergoes tyrosine 
phosphorylation at the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif. EPIYA motifs found on the 
CagA are phosphorylated and induce strong immune response. The number of EPIYA 
motifs present on CagA varies amongst the strains. Strains with high motif number show 
more biological activity, more virulence and play a potential role in development of 
gastric cancer (Higashi et al., 2002). 
1.6.2.3 Cag type IV secretion system (Cag-T4SS) 
Many gram-negative bacteria possess type IV secretion system that serves as a syringe-
like pilus structure (also called T4SS pilus) protruding from the bacterial surface and is 
driven by host cell contact to acquire genetic materials, DNA-protein complexes or to 
inject virulence factors (Kwok et al., 2007; Rohde et al., 2003). 
Type IV secretion system (T4SS) in H. pylori is responsible for injection of cytotoxin 
associated antigen A (CagA) across the bacterial cell envelopes into human gastric 
epithelial cells leading to pathogenesis (Kwok et al., 2007). The delivery of CagA by the 
T4SS requires a host cell receptor, the integrin member β1 and phosphatidylserine. 
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Numerous structural T4SS components have been demonstrated to bind to integrin β1 
including CagA, CagI and CagY but excluding CagL (Jimenez-Soto et al., 2009; 
Murata-Kamiya et al., 2010). CagL is responsible for the formation of the pilus tips of 
the T4SS that includes an arginine-glycine-aspartate (RGD) motif leading to bacteria to 
bind α5β1 integrin on the surface of target cell. CagI is another protein which plays role 
in part of cagPAI. CagM protein is important for the translocation of CagA from the 
cytoplasm to the bacterial membrane. Non-Cag-PAI proteins have also been involved in 
the CagA translocation. HopQ is one of the non-Cag-PAI proteins which is required for 
the CagA translocation (Kumar et al., 2013; Kwok et al., 2007). 
1.6.2.4 Outer inflammatory protein A (OipA) 
The outer membrane proteins of H. pylori play an important role in pathogenesis. The 
outer inflammatory protein A (OipA) is one of those membrane proteins which plays the 
key role in the bacterial adhesion to gastric cell and development of inflammation. OipA 
functional status is regulated by slipped-strand mispairing within CT dinucleotide 
repeats in the 5’ terminus of the gene. Variation in the number of CT dinucleotide 
repeats in the 5’ terminus means that an active protein may or may not be produced. This 
slipped-strand repair mechanism based on the adaptation system is called phase 
variation. When there is 6, 9, (1 + 3), (2 + 3), (1 + 2), (1 + 1 + 1), (1 + 1 + 2) or other CT 
dinucleotide repeats, peptide kept in frame which means oipA gene is “on” status. 
Otherwise, the status is “off”, which leads to nonfunctional oipA gene. OipA ‘’on’’status 
is associated with more severe gastric diseases as ulcer and gastic cancer because of 
increased bacterial adherence and colonization (Kudo et al., 2004; Yamaoka et al., 
2006). 
1.6.2.5 Blood group antigen-binding adhesion protein A (BabA) 
BabA is one of the major outer membrane proteins (OMPs) that mediates the binding of 
bacterium to the fucosylated Lewis b blood group antigen, Le
b
, and related to terminal 
fucose residues found on blood group ABO antigens that are expressed on the surface of 
the gastric epithelial cell. Lewis b-dependent attachment of H. pylori to gastric epithelial 
cell is associated with increased severity of inflammation (Rad et al., 2002). BabA 
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binding to Le
b 
is also important for induction of DNA double-strand breaks and DNA 
damage response in host cells (Toller et al., 2011). 
1.6.2.6 Duodenal ulcer promoting gene A (dupA) 
The duodenal ulcer promoting gene A of H. pylori has been identified as a novel virulent 
marker associated with an increased risk for duodenal ulcer. The dupA is located in the 
plasticity region of the H. pylori that is homologous to virB4 gene encoding a 
component protein of the T4SS in A. tumefaciens. DupA pathogenesis induces the IL-8 
production from the antrum part of the stomach leading to antrum-predominant gastritis 
which is a characteristic of duodenal ulcer. Moreover, the presence of dupA was 
associated with increased mucosal neutrophil infiltration and its presence was inversely 
related to mucosal atrophy and gastric cancer (Lu et al., 2005). 
1.6.2.7 Neutrophil - activating protein A (NapA) 
One of the most common finding in H. pylori infection is the infiltration of neutrophils 
and mononuclear cells within the gastric mucosa. There is a correlation between the 
neutrophil infiltration and mucosal damage (Davies et al., 1992; Fiocca et al., 1992). 
Neutrophil-activating protein A (NapA) is a water-soluble 150 kDa dodecameric protein 
that has been identified as a major H. pylori infection related virulence factor and 
promotes neutrophil infiltration to the site of the infection (Zanotti et al., 2002). NapA 
promotes endothelial adhesion of neutrophils and stimulates high production of oxygen 
radicals from polymorphonuclear leukocytes (PMNs). Moreover napA increases the 
synthesis of tissue factor and secretion of type-2 plasminogen activator inhibitor by 
monocytes/macrophages. NapA is localized in the cytosol of bacteria and released upon 
autolysis. Following autolysis, it binds to the external surface of the outer membrane of 
bacteria to mediate the binding of H. pylori to the cell surface of host cell via interaction 
with carbohydrates (Cover et al., 1994; Namavar et al., 1998). The production of 
reactive oxygen radicals by induced neutrophils is a key component of the innate 
immune system. Also, neutrophils are an effective antimicrobial agent against H. pylori 
as well as a factor that maintains mucosal damage and gastritis (Evans et al., 1995; Satin 
et al., 2000). 
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1.6.2.8 Putative neuraminyllactose-binding hemagglutinin homologue A (HpaA) 
H. pylori adheres to the receptor on the surface of the gastric epithelial cells by its 
adhesin molecules. HpaA is a putative neuraminyllactose-binding hemagglutinin protein 
A that enables the bacteria to adhere host gastric epithelial cells surface. HpaA has also 
been described as a flagellar sheated protein (Evans et al., 1988; Evans et al., 1993; 
Jones et al., 1997). This protein acts as hemagglutinin and aggregates with assembly of 
fibriller structure. 
1.6.2.9 UreaseA gene (ureA) and UreaseB gene (ureB) 
Urease is a pivotal enzyme for decreasing stomach acidity by generating ammonia and 
carbonate from urea (Hu & Mobley, 1990). This enzyme is necessary for H. pylori 
colonization on the gastric mucosa and a potent immunogen that draws out a vigorous 
immune response. H. pylori urease encoding genes are located as a single 6.13-kb gene 
cluster on the chromosome of the bacterium (Clayton et al., 1990; Cussac et al., 1992; 
Labigne et al., 1991). For the synthesis of an active enzyme seven contiguous genes, 
ureABIEFGH, all transcribed in the same direction are necessary (Cussac et al., 1992; 
Hu et al., 1992; Hu & Mobley, 1993). ureA and ureB are the first two genes of the gene 
cluster and their expression is sufficient to produce an assembled apoenzyme. The active 
site of the enzyme is found in the UreB subunit. The UreA subunit of Helicobacter 
species is different from the other bacterial species because its amino acid sequence is 
encoded by the single ureA gene. Two separate genes are needed for the other species 
like Escherichia coli  (Hu et al., 1992). 
1.7 Assays for Diagnosis of H.  pylori 
Diagnostic tests for H. pylori infection can be divided into two groups: invasive 
techniques, which require upper gastrointestinal endoscopy (gastroscopy) and are based 
on the analysis of gastric biopsy specimens, and non-invasive techniques such as 
serology, urea breath test, urine/blood test, or detection of H. pylori antigen in stool 
specimen. 
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1.7.1 Invasive tests 
1.7.1.1 Endoscopic diagnosis  
Endoscopic diagnosis is based on examination that requires the patient to be sedated 
before an endoscope equipped with miniature video equipment is inserted through the 
mouth and down into the upper part of the gastrointestinal tract, which includes the 
esophagus, stomach and duodenum. The gastroenterologist can then take a biopsy 
(sample of tissue) for pathological testing to determine the presence of H. pylori 
infection. Confocal endomicroscopy is one of the most impressive advances in the use of 
endoscopic techniques for visualization of H. pylori colonizing the gastric mucosa 
(Kiesslich et al., 2005). 
In the recent studies that describe gastric mucosal surface pattern with high 
magnification, a good correlation was reported between the histopathological findings 
with a sensitivity and specificity (91–100%) for H. pylori infection and gastric atrophy 
(Anagnostopoulos et al., 2007; S. Kim et al., 2006). However, the present position for 
endoscopy persists for the investigation of obstacle due to H. pylori and sampling 
biopsies for culture, histology, and rapid urease test. 
1.7.1.2 Histology 
Histologic testing is one of the most useful methods for detection of H. pylori infection. 
This test is considered as a gold standard. However, issues include size, number and site 
of the gastric biopsies, staining methods and experience of the examining pathologist 
make this test an imperfect gold standard for the detection of H. pylori infection (el-
Zimaity, 2000). On the other hand, when histology is compared to other diagnostic tests 
it has advantages of evaluation for pathologic changes related with H. pylori infection 
such as inflammation, intestinal metaplasia, athropy and malignancy (Dixon et al., 
1996). 
1.7.1.3 Culture 
Culture is used as a specific and standard diagnostic test for the most of the bacterial 
infections. However, it is time consuming and not necessary for the detection of 
relatively fastidious and slow growing microaerophilic H. pylori. Also, the sensivity of 
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culture has been found to vary between the laboratories because of the H. pylori 
distribution in stomach and challenge in collecting biopsy sample. Other invasive tests 
like histology or rapid urease test are cheaper than the culture method (Makristathis et 
al., 2004; Perez-Perez, 2000). 
In addition to being a specific and standard diagnostic test, culture has advantage of 
being able to detect bacterial drug sensitivity. It has great value to decide the subsequent 
antimicrobial treatment if a patient does not give response to standard antimicrobial 
therapy (Lehours et al., 2003). 
1.7.2 Molecular methods 
In the recent years, molecular tests have been widely used to detect H. pylori infection or 
H. pylori drug resistance based on the specific sequence of H. pylori DNA using 
different molecular techniques. 
1.7.2.1 Polymerase chain reaction (PCR) 
Many assays based on polymerase chain reaction (PCR) techniques have been employed 
to detect H. pylori DNA by using different gene targets from a variety of sources. PCR 
test has sensitivity and specificity over 95% as compared to the other tests (Lage et al., 
1995). However its application and optimization makes these tests more expensive. 
Detection of H. pylori by PCR is possible for the samples such as gastric biopsy, gastric 
juice, dental plaque, saliva, stool etc. Especially, virulence factors are the most important 
targets for PCR. 
1.7.2.2 Quantitative real-time PCR 
The detection of H. pylori DNA by real-time polymerase chain reaction (RT-PCR) is 
promising and there have been numerous studies to increase the sensitivity and 
specificity of this method. Especialy to test the drug resistance, RT-PCR is preferred 
because of its quick and accurate results (Chey & Wong, 2007). 
1.7.2.3 Multiplex-PCR  
Multiplex-PCR is a technique that is used to amplify more than one target in a single 
PCR assay. For the rapid detection of H. pylori infection as well as virulence genes and 
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drug resistance from the gastric samples, multiplex-PCR test is used. In multiplex PCR, 
by using less DNA, two or more loci can be simultaneously amplified in the same 
reaction (Chattopadhyay et al., 2004). 
1.7.2.3.1 Optimization of Multiplex-PCR 
Multiplex-PCR is a technique in which more than one target sequence is amplified using 
more than one pair of primers. The amount of reagents and preparation time is less in 
multiplex- PCR than uniplex-PCR in which several tubes are used. A multiplex-PCR 
method is ideal for conserving costly polymerase and templates in short supply 
(www.premierbiosoft.com). Even though it has many advantages, multiplex-PCR 
technique requires extensive optimization because of having many different parameters 
for each target. The most important steps in optimization of multiplex-PCR design are 
shown in Figure 1.5. The first step is optimizing all PCR parameters for single-target 
amplifications. Then, primers for each target are combined to determine which primer 
sets are compatible with each other. Also thermocycling parameters are optimized to get 
the best multiplex PCR products. The presence of more than one primer pair in the 
multiplex PCR increases the risk of obtaining non-specific amplification products, 
primarily because of the formation of primer dimers. Sometimes these nonspecific 
products are amplified more efficiently than the target product with consuming reaction 
components and producing impaired rates of annealing and extension. Primer design for 
multiplex PCR is a challenging problem. Several factors need to be considered. Primer 
pairs used in a multiplex PCR should enable similar amplification efficiencies for their 
respective target (Shen et al., 2010). Thermocycling parameters and ingredients in PCR 
are other two factors that have to be optimized firstly for each target and then for each 
multiplex PCR combinations. Annealing temperature and PCR cycle number have to be 
adjusted according to the primers’ Tm, primer and the product length. Ingredients in the 
multiplex PCR have an important effect on the PCR product.  
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Figure 1.5 : Guidelines of multiplex-PCR optimization; Primer design, primer 
validation, primer concentration, optimization of  amounts of dNTPs, 
MgCl2, polymerase, salts and the thermalcycler parameters are the factors 
that have effect on the multiplex-PCR optimization. This guide can be 
used to troubleshoot the difficulties during the optimization of multiplex-
PCR assays. 
1.7.2.4 Stool PCR 
H. pylori-infected individuals excrete H. pylori in feces; therefore the pathogen could be 
detected in stool specimens by PCR. However, false-negative and false-positive results 
are larger problem in the stool PCR, because stool samples include many chemicals, 
commensal bacteria and inhibitors. In contrast to the limitations, it is preferred compared 
to taking biopsy by the patients (Mapstone et al., 1993; Namavar et al., 1995). 
1.7.2.5 Fluorescence in situ hybridization (FISH) 
H. pylori specific DNA probes are used to detect bacterial infection in fluorescence in 
situ hybridization method. When FISH is compared to the other diagnostic methods, it is 
advantageous as it is not affected by DNA contamination and it allows direct 
22 
 
visualization of bacteria in the gastric biopsy specimens (Almeida et al., 2009; Perry-
O'Keefe et al., 2001). 
1.7.2.6 Rapid urease test (RUT) 
RUT is a widely used biopsy-based method, in a clinical practice, to detect H. pylori 
urease enzyme which promotes the survival of bacteria in the acidic stomach 
environment by breaking down the urea into carbon dioxide and amonia, in clinical 
practice (Chey & Wong, 2007). RUT detects the active H. pylori infection in a gastric 
biopsy sample using an agar gel or a reaction strip containing urea. It is a simple and a 
rapid test but its sensivity can be decreased in patients with acute ulcer bleeding and 
usage of bismuth containing compounds and antibiotics (Lee et al., 2000). 
1.7.3 Non-invasive tests 
A wide variety of non-invasive tests can be used for the initial diagnosis of H. pylori 
infection. Urine, whole blood, saliva, serum, expired air are used as a sample for these 
non-invasive diagnostic test.  
1.7.3.1 Urea breath test (UBT) 
Urea breath test is based on the analysis of enzyme activities and metabolic processes. 
The UBT has become available for clinical routine by the introduction of stable isotopes 
(Non radioactive 
13
C labeled substances). 
Normaly, urea of noninfected individuals leaves stomach unchanged unless other 
bacteria`s urease activities are present in the oral cavity. In H. pylori infected 
individuals, urea is degraded into ammonia and carbondioxide. To detect the hydrolysis 
products of urea, it is labelled by different stable isotopes such as 
13
C for 
13
CO2 in the 
expired air and 
15
N for detection of 
15
N labelled ammonia in urine. To get the best 
specificity and sensitivity from urea breath test gastric pH, age, dose and application 
tracer, and interfering drugs should be considered (Graham et al., 1987; Krumbiegel et 
al., 2000). 
14
C is also used for some breath tests, but its usage is not preferred for 
children because of its radiation (Koletzko et al., 1998). 
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1.7.3.2 Stool antigen test (SAT) 
Diagnosis of H. pylori infection in stool by using H. pylori antigen is another attractive 
non-invasive method which is very suitable for both clinical use and epidemiological 
research studies. The most common H. pylori antigen detection method in stool is 
enzyme immunoassay (EIA). Many new methods have been developed to detect H. 
pylori infection based on the stool test such as; polyclonal antibody EIA, monoclonal 
antibody EIA and immunochromatographic quick test. 
The stool antigen tests are easy to perform, independent of age and cheaper compared 
with the UBT. This test method has advantage over several others of being easily 
applicable to children (Oderda et al., 2000; van Doorn et al., 2001; Yee et al., 2002). 
1.7.3.3 Antibody tests 
H. pylori infection leads both local and systemic antibody responses in the body. After 
infection, a systemic response begins with the rising of specific IgM level and followed 
by IgA and IgG level increase throughout the infection. Detection of these antibodies are 
performed by enzyme linked immunosorbent assay (ELISA) or latex agglutination tests. 
Serum and urine are used as samples in these tests. The accuracy of antibody based 
diagnostic test is equal to the UBT (Alemohammad et al., 1993; Weston et al., 1995). 
1.8 Treatment of H. pylori Infection 
 After the discovery of H. pylori and understanding its role in gastric diseases, 
management of patients with H. pylori has changed. H. pylori eradication needs 
multidrug therapy, typically antibiotics with an acid suppressant. Many drug therapies 
have been implemented to cure H. pylori infection. Unfortunately, drug resistance is 
largely responsible for treatment failures for the H. pylori infection. New drugs are 
needed to cope with increasing prevalence of antibiotic resistance among H. pylori 
(Hunt, 1997). 
1.8.1 Standard first-line therapy 
Standard first-line therapy includes two antibiotic; amoxicillin and clarithromycin to kill 
the bacteria and a proton-pump inhibitor (PPI) to enhance the antibiotic activity, which 
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is the most commonly appointed H. pylori eradication regimen (Sasaki et al., 2013). 
However, this triple therapy may fail due to several reasons. The main reason for this 
therapy failure is resistance of H. pylori to clarithromycin (Megraud & Lamouliatte, 
2003). The bacteriostatic activity of this antibiotic depends on its inhibition activity of 
the protein synthesis by binding to the 50S bacterial ribosomal subunit. The bacterial 
resistance to macrolides such as clarithromycin depends on the point mutations in the 
peptidyltransferase region encoded in domain V of 23S rRNA. These mutations lead to 
inhibition on the binding between the clarithromycin and the ribosomal subunit 
dedicated to the specific antibiotic related protein synthesis. Mutations associated with 
clarithromycin resistance are transition of adenine to cytosine in 2143 and 2142 
positions of rRNA and the substitution of adenine with cytosine in 2142 positions of 
rRNA (Megraud, 2004; van Doorn et al., 1999; Versalovic et al., 1996). 
1.8.2 Second and third-line therapies 
After the first-line therapy failure an alternative second-line and third-line therapies can 
be used for the treatment of H. pylori infection. The second-line therapy includes proton-
pump inhibitor (PPI), bismuth, tetracycline and metronidazole. Tetracycline is one of the 
protein synthesis inhibitor antibiotics that affect cell growth by inhibiting translation 
(Brodersen et al., 2000). Metronidazol inhibits nucleic acid synthesis by disrupting DNA 
of microbial cells. When  H. pylori loses oxygen-insensitive NADPH nitroreductase 
activity which reduces an active metabolite directly toxic to the bacteria, resistance 
against to metronidazole is developed (Tomb et al., 1997). Levofloxacin-based triple 
therapy consisting of levofloxacin, amoxicillin and a PPI represents an encouraging 
strategy for second-line therapy (Saad et al., 2006). The triple therapy includes PPI, 
amoxicillin and sitafloxacin. Amoxicillin inhibits synthesis of bacterial cell wall 
(Geddes et al., 2007). Sitafloxacin is a fluoroquinolone that inhibits the topoisomerase II 
in the bacterial cell, leads to DNA fragmentation via nuclease activity of the intact 
enzyme domains (Andersson & MacGowan, 2003). 
1.8.3 Sequential and concomitant (Non-bismuth Quadruple) therapy 
The most widely recommended treatment for H. pylori infection is triple therapy 
consists of a proton pump inhibitor–based (PPI) with two antibiotics (Chey & Wong, 
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2007; Coelho et al., 2000; Gisbert et al., 2005; Lam & Talley, 1998; Malfertheiner et al., 
2007). However, eradication rate of the triple therapy has considerably fallen (Graham et 
al., 2007). Because of the antibiotic resistance, scientists have been trying to develop 
new alternative treatment regimens against the H. pylori infection.  
Sequential treatment includes 5 days of PPI treatment plus amoxicillin, followed by a 
further 5 days of PPI together with two other antibiotics, usually clarithromycin and 
metronidazole (Gisbert et al., 2010). Due to recent research, sequential regimen is more 
effective than standard triple therapy (Gatta et al., 2009; Jafri et al., 2008; Moayyedi, 
2007; Tong et al., 2009; Zullo et al., 2007). 
Concomitant (Non-Bismuth quadruple) treatment includes three clarithromycin, 
amoxicillin and metronidazole or tinidazole together with the PPI for the duration of 
therapy. Concomitant treatment is an effective, safe, and well-tolerated alternative to 
triple therapy and also this treatment is less complex than sequential therapy (Graham & 
Shiotani, 2008). 
1.8.4 Levofloxacin and other fluoroquinolones 
Levofloxacin is one of the fluoroquinolones that shows its function on type II 
topoisomerase enzymes. One of the type II topoisomerase enzymes affected by 
levofloxacin is DNA gyrase which is responsible for supercoiling the DNA. When there 
is an effect on this enzyme; DNA cannot be supercoiled and does not fit the newly 
duplicated cells. The other ezyme is a topoisomerase IV which is necessary to separate 
DNA that has been replicated prior to bacterial cell division. When replicated DNA is 
not separated, the bacterium cannot divide (Drlica & Zhao, 1997; Mutschler et al., 
2001). Another and newer fluoroquinolone agent used for H. pylori therapy is 
sitafloxacin. It has in vitro activity against gram-negative bacteria including H. pylori 
(Sanchez et al., 2000). 
1.8.5 Bismuth-based therapies 
Bismuth is a heavy metal that is used as anti-H. pylori agent due to its effect on bacterial 
iron uptake. Bismuth is used as combination with metronidazole and tetracycline or 
amoxicillin in the triple therapy (de Boer, 1999) and it was reported that this therapy 
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cures 87.9% of patients within one week of treatment and 89.2% of patients within 2 
weeks of treatment (Tytgat et al., 1990). 
1.8.6 Probiotics 
Antimicrobial treatments for H. pylori infection are highly effective, but it is expensive. 
Antibiotics have side effects and sometimes antibiotic resistance can be a considerable 
problem. Probiotics are used as an alternative solution to treat H. pylori infection. 
Probiotic bacteria can act on H. pylori by the help of several putative mechanisms; 
intake of probiotics strengthens the nonimmunological barrier of stomach; produces 
antimicrobial substances to inhibit H. pylori colonization, stimulates mucin production, 
and stabilizes the gut mucosal barrier (Jack et al., 1995; Vandenberg, 1993). Also, 
attachment of H. pylori to gastric epithelial surface can be inhibited by probiotics. 
Probiotics can lead to increase in the amount of mucin secretion of stomach and 
modifications in the immunologic response of the host (Gill, 2003). L. acidophilus 4356, 
L. casei 193, L. lactis BH5, B. subtilis, W. confusa PL9001 are some probiotics 
microorganisms used for the tretment of H. pylori infection (Rolfe, 2000). 
1.9 Immune Response to H. pylori Infection 
The host immune response against bacterial pathogen is divided into innate and adaptive 
response. When the host is infected with a bacterial pathogen innate immune response 
shows a quick and non-specific process and reacts with bacterial molecules to signal 
infectious danger aiming to kill bacteria (Portal-Celhay & Perez-Perez, 2006). Toll-like 
receptors (TLRs) expressed on antigen-presenting cells (APCs) such as dentritic cells 
(DCs) and monocytes mediate innate immune response towards bacterial infections. 
When bacteria contact with APCs and monocytes proinflammatory cytokines are 
secreted such as tumor necrosis factor α (TNF- α), Interleukin 8 (IL-8) and Interleukin 1 
β (IL-1 β). For H. pylori infection, these cytokines act as local chemo-attractants and 
induce granulocytic infiltration (Crabtree, 1996). When failure of innate immune 
response about elimination of pathogen occurs, adaptive immune response elicits a 
delayed, antigen specific response and activates T-, B- and memory cells.  
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The adaptive immune response can be divided into cellular and humoral immune 
response. Inflammatory reactions caused by H. pylori are defined by a mucosal 
infiltration of many cells like polymorphonuclear leukocytes (PMN), T cells, plasma 
cells, and macrophages. Adhesion of H. pylori to gastric mucosa and secretion of 
different molecules change gastric epithelial cell function (Ihan et al., 2012). As an 
humoral response, H. pylori infection induces specific systemic and local antibody 
response. Also, infected individuals secrete antibodies against the bacteria (Mattsson et 
al., 1998). 
1.9.1 T cells’ development and types of T cells  
T cells are a subset of lymphocytes that play a central role in cell-mediated immunity. 
They can be distinguished from other lymphocytes, such as B cells and natural killer 
cells (NK cells), as having a T-cell receptor (TCR) on their cell surface. T-cell receptors 
detect fragments of antigens on the surfaces of infected or cancerous cells (Alberts, 
2002). T cell development and maturation involve a complex variety of interactions with 
non-lymphoid cell products and receptors. All progenitors of T cells originate from 
haematopoietic stem cells in the bone marrow. Haematopoietic progenitors enter the 
thymus and differentiate, undergo selection, and eventually mature into functional T 
cells (Schwarz & Bhandoola, 2006). Complex transcriptional network, specific receptor-
ligand pair interactions and sensitization to trophic factors play role in this process that 
mediates homing, proliferation, survival and differentiation of developing T cells (Koch 
& Radtke, 2011). In the thymus, T cells develop their specific T cell markers, including 
TCR, CD3, CD4 or CD8, and CD2. CD4
+ 
T cells are classified into two main classes; T 
helper cell 1 (Th1) and T helper cell 2 (Th2) on the basis of cytokines and transcription 
factors. T helper 17 (Th17), T helper 9 (Th9) and T helper 22 (Th22) are newly 
described CD4
+ 
T cells that have a crucical role in the pathogenesis of various immune 
diseases (Figure 1.6).  
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Figure 1.6 : CD4
+
 T helper cells differentiation; functions, unique products, 
characteristic transcription factors and cytokines critical for  
fate determination. 
1.9.1.1 T helper 1 cell (Th1) 
One of the first described T helper cells are T helper 1 cells (Th1). Th1 cells are a 
lineage of CD4
+
 effector T cells that secrete signature cytokine interferon-γ (IFN-γ), 
Interleukin 2 (IL-2) along with other pro-inflammatory cytokines, like tumour necrosis 
factor-α (TNF-α) and TNF-β. Th1 cells induce macrophage activation, nitric oxide 
production, and cytotoxic T lymphocyte proliferation, leading to phagocytosis and 
destruction of microbial pathogens. Interleukin 27 (IL-27), interleukin 12 (IL-12) and 
IFN-γ are cytokines that take part in Th1 cell differentiation and expansion together with 
a subset of specific cell surface receptors including IL-12 R beta 2, IL-27 R alpha/WSX-
1, IFN-γ R2, CCR5 and CXCR3. STAT1-dependent expression of T-bet, Th1-specific 
transcription factor and a master regulator of Th1 differentiation are induced by IL-27 
signaling in naive CD4
+
 T cells. T-bet is a member of T-box family of transcription 
factors and is the only known T-box gene that specifically expressed in the lymphoid 
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system. T-bet assists expression of IFN-γ and IL-12 R beta 2. IL-12 R beta 2 
heterodimerizes with IL-12 R beta 1 to make a functional IL-12 receptor complex that 
then stimulates STAT4-dependent IFN-γ production and Th1 differentiation (J. Zhu & 
Paul, 2008). 
IFN-γ has been accepted as an important cytokine that play role in the differentiation of 
Th1 cells. However, Interleukin-12 (IL-12) is also a potent inducer of Th1 
differentiation (Hsieh et al., 1993; Seder et al., 1993; Swihart et al., 1995; Wang et al., 
1994; Wenner et al., 1996). Both IFN-γ and IL-12 function through promoting 
expression of Th1-specific transcription factors that are STAT1, STAT4, and T-bet.  
Th1 cells promote cell-mediated immunity characterized by cellular cytolytic activity 
and protect the host from the obligate intracellular pathogens. On the other hand, 
excessive pro-inflammatory activities of Th1 can lead tissue damage and elicit unwanted 
inflammatory diseases as well as autoimmune disorders such as insulin-dependent 
diabetes mellitus
 
and rheumatoid arthritis disease
 
and graft-versus-host disease 
(Davidson et al., 1996; Hu et al., 1999; Leung et al., 2000; B. Wang et al., 1997). 
IFN-γ, also known as Type II interferon or immune interferon, is a cytokine that is 
critical for innate and adaptive immunity against viral, bacterial and protozoal infections. 
This cytokine promotes protection against intracellular pathogens. IFN-γ is produced 
primarily by CD4
+
 T helper 1 (Th1) and CD8
+
 cytotoxic T lymphocyte (CTL) as part of 
antigen-specific immunity and by natural killer (NK) and natural killer T (NKT) cells 
once innate immune response develops (Schoenborn & Wilson, 2007). 
IFN-γ activates macrophages’ effector functions, affects isotype switching and 
potentiates the secretion of immunoglobulins by B cells. Also, this cytokine upregulates 
expression of class I and II major histocompatibility complex (MHC) molecules, Fc 
receptor and leukocyte adhesion molecules those are important for adaptive immune 
response against pathogens. IFN-γ promotes differentiation of naive T helper cells into 
Th1 cells and suppresses Th2 cell differentiation. IFN-γ acts by binding to specific cell 
surface receptors with high-affinity binding sites (Schroder et al., 2004). 
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1.9.1.2 T helper 2 cell (Th2) 
T helper type 2 cells are a distinct lineage of CD4
+
 effector T cell that secretes IL-4, IL-
5, IL-9, IL-13, IL-10 and IL-17E/IL-25. Th2 cells are associated with humoral immunity 
and important in coordinating the immune response to large extracellular pathogens. IL-
4 is the most potent cytokine that is required for Th2 priming, maturation and 
differentiation (Le Gros et al., 1990; Swain et al., 1990). GATA binding protein 3 
(GATA-3) is a member of the GATA family of transcription factors that is required for 
Th2 differentiation (Ouyang et al., 1998; Pai et al., 2004). The high concentrations of 
Th2 can block generation of Th1 cells from naive T cells. 
1.9.1.3 T helper 17 Cell (Th17) 
T helper 17 cell is a newly identified, independent subset of T helper cells. Interleukin 
17 (IL-17) cytokine family, including IL-17A (commonly referred to as IL-17), IL-17B, 
IL-17C, IL-17D, IL-17E (also known as IL-25) and IL-17F are secreted by Th17 cells. 
Th17 cells play an important role in host defense against fungal and bacterial infection, 
especially at mucosal surfaces. IL-17 and IL-22 production triggers generation of Th17 
cell, which improves mucosal barrier surfaces by stimulating release of antimicrobial 
peptides and recruiting neutrophils (Harrington et al., 2005). Both transforming growth 
factor-β (TGF-β) and IL-6 act cooperatively and non-redundantly to improve Th17 
commitment.  IL-6 induces Th17 cells along with TGF-β (Zhou et al., 2007). Retinoic 
acid-related orphan receptor gamma (RORγ) is a “master-regulator” transcription factor 
that controls differentiation of Th17 cells. ROR-α and ROR-γt are critical in promoting 
Th17 cell differentiation (Jin et al., 2010). 
IL-17 is a potent proinflammatory cytokine that intensifies ongoing inflammation by 
activating expression of tumor necrosis factor-α (TNF-α), IL-1β, and IL-6 in epithelial 
and endothelial cells. IL-17 is the signature cytokine of T helper 17 cells. IL-17 is 
produced by natural killer cells after stimulation of T-cell antigen receptor (Weaver et 
al., 2007). 
Human IL-17 gene has 1874 base pairs in length and it was derived from CD4
+
 T cells 
(Yao et al., 1995). There are several proteins homologous to IL-17, which includes IL-
17B, IL-17C, IL-17D, IL-17E, and IL-17F. Expressions of IL-17A and IL-17F appear to 
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be restricted to a small group of activated T cells and upregulated during inflammation. 
Expression of IL-17B occurs in several peripheral tissues and immune tissues. IL-17C is 
upregulated in inflammatory conditions and IL-17D is highly expressed in the nervous 
system and in skeletal muscle. IL-17E is expressed at low levels in various peripheral 
tissues (Aggarwal & Gurney, 2002). 
RAR-related Orphan Receptor Gamma t (RORγt) is one of the members of the nuclear 
receptor family of intracellular transcription factors that play critical roles during 
homeostasis and specific stages of development. ROR-α, -β, and –γ are three forms of 
RORs and they have different roles. ROR-α plays role in the development of the 
cerebellum and lymph nodes, lipid metabolism, immune response, and maintenance of 
bone. ROR-β is highly expressed in the brain and retina, but the exact role is not known. 
ROR-γ is participated in lymph node development and immune response and survival of 
T helper 17 cells. Differentiation of Th17 requires transforming growth factor-beta but 
also depends on distinct transcription factors such as RORγt (Hirose et al., 1994). 
RORγt is selectively expressed in Th17 cells differentiated in the presence of TGF- β 
plus IL-6 and transduction of naive T cells with retroviral vector containing RORγt 
induces the development of Th17 cells (Ivanov et al., 2006). 
1.9.1.4 T helper 9 cell (Th9)  
T helper 9 cells that are characterized by expression of high level of interleukin 9 (IL-9) 
have been recently described. Th9 cells enhance the pro-inflammatory Th17 cell- driven 
immune response and prevent allograft rejection by intermediating the T cell tolerance 
(Annunziato & Romagnani, 2009).  
1.9.1.5 T helper 22 cell (Th22)  
T helper 22 (Th22) cells are subset of human CD4
+
 effector T cells that primarily secrete 
IL-22, IL-13, and TNF-alpha. Th22 cells have been found in the epidermis of 
inflammatory skin disorders and they are believed to be important to contribute to the 
host defense against microbial pathogens and promote tissue repair or remodeling (Basu 
et al., 2012). 
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1.9.2 Regulatory T cell (Treg) 
Regulatory T (Treg) cells, known as suppressor T cells, form a subset of CD4
+
 T cells 
that develop in the thymus (nTreg; naturally occurring) or comprehend from naive T 
cells in the presence of TGF-β ensuing T-cell receptor stimulation (iTreg; induced Treg) 
in the periphery. Treg cells are immune-suppressive cells that are distinct from other 
immune response promoting Th cells. The most important function of Treg cells is 
maintaining self-tolerance and immune homeostasis (Sakaguchi, 2004; Shevach, 2000). 
Also, Treg cells are crucial for tempering immune responses against infectious agents 
and renewing immune homeostasis after pathogen clearance (Belkaid, 2008). Forkhead 
Box P3 (FOXP3) is a transcription factor expressed in Treg cells. FOXP3 is known as 
the master regulator of Treg function. Tregs control expression of a wide array of genes 
including cytokines and surface molecules playing a suppressive role in the immune 
system (Zheng & Rudensky, 2007). 
FOXP3 acts as master switch gene in the development and function of regulatory T cells 
(Zhang & Zhao, 2007). FOXP3 transcription factor occupies the promoter region of 
genes that involved in regulatory T-cell function and could suppress transcription of key 
genes subsequent to stimulation of T cell receptors (Marson et al., 2007). Molecular 
mechanisms behind the expression of FOXP3 gene are incompletely understood. 
However, it is known that TGF-β, IL-2 or TCR stimulation of T cells can all result in 
increased FOXP3 expression (Kim & Leonard, 2007). 
1.9.3 The role of T cells in the H. pylori infection 
CD4
+
 T helper cells can be differentiated to Th1, Th2, Th17 and Treg cells according to 
the induction of various cytokines and transcription factors. Especially, Th1 and Th17 
cells together with Tregs play important roles on the H. pylori-induced immune 
response. The number of Th1, Th2 and Th17 cells increase in H. pylori-infected gastric 
lamina propria. These cells play important roles in pathogenesis of bacterial infection by 
increasing inflammation (Razavi et al., 2015).  
In general, Th1 cell responses are induced most by intracellular bacteria, whereas Th2 
cell responses are stimulated by extracellular parasites including helminths. Previously, 
it was shown that gastric lymphocyte populations from H. pylori-infected patients 
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contain increased IFN-γ-producing T cells, consistent with a Th1 cytokine response. 
Moreover,   H. pylori-specific T cell clones derived from gastric mucosa of the patients 
with peptic ulcer disease had a Th1-profile (Ekkens et al., 2007). Abundant levels of 
Th1 cytokines, IFN-γ and IL-2, and low levels of Th2 cytokines, IL-4 and IL-5, are 
produced by the T cells harvested from H. pylori-infected individuals. The adaptive 
immune response to H. pylori is composed of both Th1 and Th2 type cells, but cytokine 
profiles indicate predominance of a Th1 response in H. pylori-infected patients. The Th1 
proliferation in H. pylori-infected gastric mucosa involves signals provided by antigen-
presenting cells and cytokines produced in response to the components of the pathogen, 
such as lipopolysaccharide, resulting in increased secretion of IFN-γ, IL-12, and IL-18 
(Larussa et al., 2015).  
A novel subset of effector T cells, pro-inflammatory Th17 cells, is identified by 
secretion of IL-17A, IL-17F, IL-21, and IL-22. By promoting chronic inflammation, 
Th17 cells are clearly implicated in the pathogenesis of autoimmune diseases and in the 
protective immunity against extracellular bacterial infections. However, the protective 
and pathogenic functions of IL-17 producing Th cells were also reported in infections. 
Several publications have reported that, H. pylori infection increases IL-17 in the gastric 
mucosa. IL-17 production has shown to be crucial for neutrophil recruitment to the H. 
pylori-infected gastric mucosa (Shi et al., 2010). 
H. pylori-specific regulatory T cells (Treg) suppress elevated activation of effector CD4
+
 
T cells as well as effector CD8
+
 T cells. This leads to control of gastric inflammation 
and persistent colonization of the bacterium. As reported in a recent study, H. pylori-
infected individuals have increased number of regulatory T cell (Treg) cells in the 
stomach and duodenal mucosa compared to uninfected controls (Lundgren et al., 2013). 
Treg cells are present in the mucosa of individuals with asymptomatic H. 
pylori infections as well as in duodenal ulcer patients. Also, the frequency of Treg cells 
increase in the stomachs of H. pylori-infected patients with gastric adenocarcinoma 
(Lundgren et al., 2005). These findings suggest that Treg cells could suppress mucosal 
immune responses and contribute to the persistence of H. pylori infections (Larussa et 
al., 2015).  
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1.10 Hypothesis 
H. pylori has been recognized as the main risk factor for gastritis, peptic ulcer, gastric 
carcinoma and gastric mucosa- associated lymphoma. The clinical outcomes of H. pylori 
infection is highly variable and is influenced by bacterial virulence factors, host genetic 
factors, and immune responses. H. pylori virulence factors have been correlated with 
specific manifestations of the disease and expound mechanisms of pathogenesis. The 
important H. pylori virulence factors, which play roles in the disease process, are the 
cytotoxin associated gene A (cagA), vacuolating cytotoxin A (VacA), outer 
inflammatory protein A (OipA), blood group antigen-binding adhesion (BabA), putative 
neuraminyllactose-binding hemaggluttinin homolog A (HpaA), neutrophil activating 
protein A (NapA), duodenal ulcer promoting gene A (dupA), urease subunit A (UreA), 
urease subunit B (UreB). Another factor that is important in H. pylori -driven disease 
process is the host’s immune response. Both CD4+ T effector  cells and 
CD4
+
CD25
+
 regulatory T (Tregs) cells are increased in gastric mucosa and peripheral 
blood of H. pylori infected patients. The impact of virulence factors on the interplay 
between CD4
+ T cells and H. pylori have not been elucidated in detail. Therefore, the 
aim of the study was to investigate the influence of nine major H. pylori specific 
virulence factors; CagA, VacA, OipA, BabA, HpaA, NapA, DupA, UreA, UreB on 
CD4
+ 
T cell response (Th1, Th17 and Treg) in H. pylori- infected gastritis and ulcer 
patients. Firstly a multiplex-PCR assay for the simultaneous detection of nine selected 
H. pylori virulence factors was developed. Secondly, the expression levels of Th1, Th17, 
and Treg specific cytokines and transcription factors were assessed in H. pylori infected 
gastritis and ulcer patients. Finally, expert-derived models for diagnostic prediction of 
gastric diseases using H. pylori virulence factors and host immune responses, was 
developed.  
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2. MATERIALS AND METHODS 
2.1 Materials and Laboratory Equipments 
2.1.1 Equipment 
The laboratory equipments used in this study were listed in Appendix A. 
2.1.2 Chemicals and kits  
The chemicals and kits used in this study were given in Appendix B together with their 
suppliers. The preparation and compositions of buffers and solutions were shown in 
Appendix C. 
2.2 Selection of Patients  
Biopsy specimens were obtained from the patients who underwent endoscopy due to 
gastroduodenal -complaints at the Gastroentorology Department of Acibadem Hospital 
Groups, in Istanbul, Turkey. In total, 109 (87 with gastritis and 22 with ulcer) patients 
were selected who fulfilled the following criteria for obtaining expulsion: under 18 
years, 65 years or older patients with active infection, cancer patients, patients with 
inflammatory diseases, patients who have had gastrointestinal bleeding within the last 
month and who have had previous gastrointestinal surgery, patients diagnosed with 
chronic liver failure, known renal failure, diabetic patients, pregnant women and patients 
who have previously received H. pylori eradication treatment, immunosuppressive 
therapy (including steroids), patients who have had nonsteroidal anti-inflammatory 
drugs (NSAIDs) and / or antibiotic treatment in the last three weeks, antisecretory 
therapy in the last two weeks and patients who refused to sign the informed consent 
form. However, 29 of 109 patient samples were then eliminated after they were found to 
be H. pylori negative with urease PCR and histopathological staining; thus, 80 patients 
(62 with gastritis and 18 with ulcer) were included in this study. Each participant 
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provided a written informed consent to participate to the study and the ethical committee 
of Acıbadem University and Istanbul Technical University approved the study. Eighteen 
participants in the control group were selected from the patients who underwent routine 
endoscopic examination and had negative rapid urease test results for H. pylori.  
2.3 Gastric Biopsy Specimens 
Two gastric biopsy specimens were taken from the antrum and corpus parts of the 
stomach of the patients during endoscopy, one for DNA isolation and the other for RNA 
isolation. Fresh biopsy specimens were placed into a preservative solution (Ambion, 
RNAlater® RNA Stabilization Solution), kept overnight at + 4°C, and then placed at – 
80°C until DNA and RNA isolation. 
2.4 RNA Extraction 
To study gene expression, RNA was isolated from RNALater-stabilized human tissue 
specimens. Frozen biopsy specimens were homogenized by using a high efficiency 
homogenization system (SpeedMill PLUS, Analytikjena) and total RNA was isolated 
using RNA isolation kit, following the protocol recommended by the manufacturer 
(innuSPEED tissue RNA kit Analytikjena). All RNA samples were quantified using 
NanoDrop (ND-2000, ROCHE) and maintained in – 80 °C deep freezer until cDNA 
synthesis. cDNA was synthesized using 1 μg of RNA through a reverse transcription 
reaction (High Capacity cDNA Reverse Transcription 127 Kit, Applied Biosystems). 
2.5 DNA Extraction 
To study virulence factors of H. pylori, DNA was extracted immediately after RNA 
isolation by using a DNA isolation kit (Quick g-DNA
TM
 130, ZYMO RESEARCH) 
following the manufacturer’s description. All DNA samples were quantified using 
NanoDrop (ND-2000, ROCHE) and maintained in – 80 °C deep freezer. Also, integrity 
of the DNA samples was assessed with the gel electrophoresis. 
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2.6 Primer Design 
Primers, obtained from Metabion International AG, Germany were used in this study. 
For the PCR assay primers, GenBank entries were searched for the selected virulence 
genes sequences including ureA, ureB, cagA, oipA, hpaA, babA, dupA, and napA. The 
primers were designed by using Primer 3 software (Table 2.1). For amplification of vacA 
s1/s2, vacA m1/m2 genes previously published PCR primers (Table 2.1) were used. For 
the quantitative RT-PCR assay primers, GenBank entries were searched for sequences of 
the genes encoding human IFN-γ, T-bet, IL-17, RORγt, FOXP3. The published 
sequences were aligned and primers were designed by using the LightCycler probe 
design software (Roche Diagnostics, Mannheim, Germany) (Table 2.2). A BLAST 
search was performed to confirm the specificity of the DNA sequences of all the primers 
("The National Center for Biotechnology Information,"). 
Table 2.1 : Multiplex-PCR primers designed for the amplification of  H. pylori 
virulence genes. 
DNA region(s) Primer Name Sequences (5′→3)  PCR amplified 
Product 
Size (bp)       
References 
ure A 
ure A-F 
ure A-R 
TGA TGG GAC CAA CTC GTA ACC GT 
CGC AAT GTC TAA GCG TTT GCC GAA 
244 This study 
ure B 
Ure B-F AGT AGC CCG GTG AAC ACA ACA TCCT 
645 This study 
Ure B-R ATG CCT TTG TCA TAA GCC GCT TGG 
cag A 
Cag A-F AGAGCAAGCGTTAGCCGATCTCAA 
415 This study 
Cag A –R TTTCCCTACACCACCCAAACCACT 
hpa A 
hpa A-F 
hpa A-R 
TAG TGG GAT GCA GCC CGC ATA TTA 
CGC TAT GGC TTG AAT GGG TGG TTT 
534 This study 
oip A 
Oip A-F GTT TTT GAT GCA TGG GAT TT 
401 (Veralovic, 1991) 
Oip A-R GTG CAT CTC TTA TGG CTT T 
bab A 
Bab A-F 
Bab A-R 
AAT CCA AAA AGG AGA AAA AGT ATG AAA 
TGT TAG TGA TTT CGG TGT AGG ACA 
832/601 (Pavithran, 2002) 
dup A 
dupA-F TGA GCG TGG TAG CTC TTG AC 
584 This study 
dup A R GAG CGC GTT AGC GAT ATA GG 
nap A 
napA-F GAA TGT GAA AGG CAC CGA TT 
304 This study 
napA-R ATC GTC CGC ATA AGT TAC GG 
vac A s1/s2 
vac A s1/s2-F 
vac A s1/s2-R 
ATG GAA ATA CAA CAA ACA CAC 
CTG CTT GAA TGC GCC AAA C 
259/286 (Atherton et al., 1995) 
vac A m1/m2 
vac A m1/m2-F 
vac A m1/m2-R 
CAA TCT GTC CAA TCA AGC GAG 
GCG TCTVAAA TAA TTC CAA GG 
567/642 (Atherton et al., 1999) 
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Table 2.2 : Quantitative RT-PCR primers designed for the detection of Th1,Th17 and 
Treg cell response. 
Primer Name Sequences     (5′→3) References 
IL-17-F 
IL-17-R 
CCTGGGAAGACCTCATTGGT 
ATTCCAAGGTGAGGTGGATCG 
This study 
RORγt-F 
RORγt-R 
CTGCAAAGAAGACCCACACC 
GCAGTTCTGCTGACGGGT 
This study 
IFN-γ-F 
IFN-γ-R 
TCCAAAAGAGTGTGGAGACCA 
TCGACCTCGAAACAGCATCT 
This study 
FOXP3-F 
FOXP3-R 
TGACAGTTTCCCACAAGCCA 
GAAGATCTCGGCCCTGGAAG 
This study 
2.7 Optimization of Multiplex-PCR Assay 
To optimize the concentrations of the conventional multiplex-PCR components, the 
specificity of each primer pair and the thermocycling parameters for each virulence 
factor were tested individually in separate reactions by using genomic DNA isolated 
from H. pylori G27 strain as a positive control. Thermal cycling parameters, such as 
annealing time and temperature, extension time and temperature, cycling number were 
optimized for each primer pair. Also, the PCR assay mixture parameters were optimized. 
Obtaining the best amplification depends on template, buffer and dNTPs and Mg
++
 
concentration. Mg
++
 concentration optimization was done for each primer. Also, to 
enhance the fidelity of polymerization without reducing the yield of PCR, different 
amounts of dNTPs were studied. Also different polymerase enzymes and PCR master 
mixes were studied to get the best PCR amplification. After all these optimizations, 
different primer pair combinations were studied to find the most compatible for 
multiplex-PCR. Each thermal cycling parameters and PCR assay mixture parameters 
were optimized for each primer pair. 
2.8 Multiplex-PCR Assay 
Genomic DNA isolated from H. pylori G27 strain used in this study was a kind gift from 
Prof. Dr. Anne Mueller from University of Zurich, Institute of Molecular Cancer 
Research, Switzerland. Genomic DNA of H. pylori G27 strain and DNA obtained from 
gastric specimens were used as template DNAs in multiplex-PCR assays. The 
amplification reactions were carried out in a total volume of 25 μl and amounts used in 
reaction are given in Table 2.3. PCR conditions performed are given in Table 2.4. The 
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PCR products were subjected to electrophoresis on agarose gels and stained with SYBR 
Gold (Invitrogene). The specificity of the primer pairs was confirmed by employing H. 
pylori G27 strain as a positive control. 
Table 2.3 : PCR assay components. 
Component Amount 
10X DreamTaq Buffer (includes 20 mM MgCl2), 2,5 µl 
dNTP (200 μM) 2,0 µl 
Frw Primer (20 µM) 1 µl 
Rev Primer (20 µM) 1 µl 
Dream Taq DNA polymerase (0,65 U) 0,69 µl 
PCR Grade water 18,81 µl 
Table 2.4 : Reaction conditions of multiplex-PCR. 
Temperature Time 
95°C 3 min. 
95°C 45 sec. 
                      45 sec.     (45 cycles) 
2 min. 
60 °C 
72°C 
72°C 5 min. 
4°C ∞ 
2.9 Quantitative Real-Time PCR 
Optimal annealing temperatures of the qRT- PCR primer pairs and expected product size 
were determined with conventional RT-PCR. SYBR Green qRT-PCR amplifications 
were performed using a LightCycler 480 Real-Time Detection System (ROCHE). All 
qRT-PCR experiments were carried out in duplicate with a reaction volume of 10 μl, 
using 96-well optical grade PCR plates (ROCHE) covered with optical-quality sealing 
film (ROCHE). All qRT-PCR experiments were carried out three times independently. 
Negative controls without cDNA and positive controls for these genes were included in 
the experiments. The efficiency of qRT-PCR amplification was optimized for each 
primer pair, using various dilution series of cDNA. Amounts used in reaction are given 
in Table 2.5. PCR conditions performed are given in Table 2.6. The percentage of 
expression of the cytokines and the transcription factors were calculated from 
quantitative RT-PCR results based on the cycle threshold (Ct). Relative quantification 
method was used to analyze the PCR. Relative quantification describes the change in 
expression of the target gene relative to the Hp negative control group. 2
-
 Method 
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is used to calculate relative changes in the gene expression determined by the 
quantitative RT-PCR and as an internal control 18S rRNA housekeeping gene primers 
were used to normalize the quantitative RT-PCR. 95% confidence intervals (CIs) were 
calculated to measure the positivity of the IFN-γ (Th1), IL-17 (Th17), and FOXP3 
(Treg) on samples from patients with gastritis and ulcer. 95% confidence intervals (CIs) 
were calculated as the average of the sample plus two-standard deviation (95% CI= 
average + 2σ) for the samples in the control group that were H. pylori negative. Samples 
over the 95% confidence intervals were accepted as positive. And correlations of these 
results with the virulence factors were adapted to expert derived models.  
Table 2.5 : PCR assay components. 
Component Amount 
Power Sybr Master Mix (2X) 5 µl 
Frw Primer (10 µM) 0.5 µl 
Rev Primer (10 µM) 0.5 µl 
PCR Grade water 1.5 µl 
Table 2.6 : Reaction conditions of Real-Time PCR. 
Temperature Time 
95°C 10 min. 
95°C 15 sec. 
                    1 min.     (40 cycles) 
1,5 min. 
Depends on primer  
72°C 
72°C 5 min. 
4°C ∞ 
2.10 Multiplex Urease PCR Assay 
For rapid identification of H. pylori with urease (ure) gene-based PCR assay, genomic 
DNA from several biopsy samples and primer sequences were evaluated. ureA and ureB 
are the target genes for the urease activity of H. pylori. To optimize the multiplex urease 
PCR genomic DNA isolated from H. pylori G27 strain is used. The amplification 
reactions were carried out in a total volume of 25 μl and amounts used in reaction are 
given in Table 2.7. PCR conditions performed are given in Table 2.8. The PCR products 
were subjected to electrophoresis on agarose gels and stained with SYBR Gold 
(Invitrogene). The specificity of the urease primer pairs was confirmed by employing a 
positive and several negative controls. 
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Table 2.7 : PCR assay components. 
Component Amount 
10X DreamTaq Buffer (includes 20 mM MgCl2), 2,5 µl 
dNTP (200 μM) 2,0 µl 
Frw Primer (20 µM) 1 µl 
Rev Primer (20 µM) 1 µl 
Dream Taq DNA polymerase (0,65 U) 0,69 µl 
PCR Grade water 18,81 µl 
Table 2.8 : Reaction conditions of multiplex-urease PCR. 
Temperature Time 
95°C 3 min. 
95°C 45 sec. 
                      45 sec.     (45 cycles) 
2 min. 
60 °C 
72°C 
72°C 5 min. 
4°C ∞ 
2.11 Statistical Analysis 
Statistical analysis of correlation between H. pylori virulence factors and gastric disease 
type (i.e. Gastritis or Ulcer) was performed using two-tailed Fisher’s exact test to 
examine the significance of the association. Additionally, correspondence between 
virulence factor presence and immune response was assessed with Pearson product-
moment correlation coefficients. However, observing a strong correlation by chance is 
not uncommon for small sample sizes. Therefore, interpretation of correlation 
coefficients without any significance testing may be misleading. Statistical significance 
of sample correlation coefficients (r) was assessed using two-tailed t-test under null 
model  = 0, where  denotes population correlation coefficient. Test statistic for this 
test was calculated as following: 
 
where N denotes sample size. Associated p-value is calculated using a t-distribution with 
N-2 degrees of freedom (Evans et al., 1996). Statistical significance of correlations 
between virulence factors and immune response factors was assessed using a t-test.   
To understand the performance of the predictive expert-derived models confusion 
matrices that reports the number of false positives, false negatives, true positives, 
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and true negatives were used. Differences at P < 0.05 were accepted as statistically 
significant. All calculations were performed using R (version 3.1.0, The R Foundation 
for Statistical Computing, Vienna, Austria; http://www.r-project.org) ("The R 
Foundation for Statistical Computing,"). 
2.12 Expert-Derived Models for Diagnostic Prediction 
Classification of samples into gastritis and ulcer classes by using the virulence factors 
and the immune response results was performed by expert-derived model. The model is 
built on a randomly selected training data to discover potentially predictive 
relationships. The randomly selected training data consisted of two-thirds of the all 
dataset. Model building was performed by determining the most important feature first 
that can distinguish the ulcer and gastritis patients, and adding other features if they 
improve the overall accuracy of the prediction. Then best model was selected and 
validated on a test set. Remaining one third of the data was randomly selected as testing 
set, and this process is, repeated for 1000 times. Classification performance was assessed 
using prediction accuracy for each class. Mean of accuracies and their standard 
deviations were reported. All calculations were performed using R (version 3.1.0, The R 
Foundation for Statistical Computing, Vienna, Austria; http://www.r-project.org) ("The 
R Foundation for Statistical Computing"). Confusion matrix was calculated for the 
expert-derived models to show the number of correct and incorrect predictions ability of 
the models. Each column of the confusion matrix represents the instances in a predicted 
class while each row represents the instances in an actual class or vice-versa (Stehman, 
1997).  
2.13 Evaluation of The Functional Status of oipA Gene 
The oipA was characterized by CT dinucleotide repeats in the signal-coding region of 
the gene. A PCR sequencing-based methodology was applied to detect the number of the 
CT dinucleotides repeats in the oipA genes and, therefore, to attempt assessment of its 
expression status. The PCR amplifications were performed in a total volume of 25 μl 
and amounts used in reaction are given in Table 2.3. PCR conditions performed are 
given in Table 2.4. The resulting PCR products were subjected to gel electrophoresis in 
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a 2% agarose gels and stained with SYBR Gold (Invitrogene). Sequences of amplicons 
were directly determined, with the same forward and reverse primers employed as in the 
PCR assays, using the High-throughput Sanger sequencing (GATC BIOTECH).  
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3. RESULTS 
3.1 Detection of H. pylori by Multiplex Urease PCR 
Two subunit genes, ureA and ureB encode urease, which is the enzyme that contributes 
to the survival of bacteria in the acidic environment of the stomach. To determine the 
presence of H. pylori in human gastric biopsy specimens, we assessed the expression 
status of  ureA and ureB by multiplex-PCR assay. We utilized H. pylori strain G27 with 
a known complete genome sequence (Tomb et al., 1997 ) to optimize multiplex-PCR to 
detect H. pylori virulence factor genes, ureA and ureB genes. As a result of optimization 
studies, ureA and ureB genes were detected in a single PCR assay (Figure 3.1).  
Next, we used multiplex-urease PCR assay to detect the presence of H. pylori in gastric 
biopsy specimens of 109 patients. In total 80 of these patients were detected as H. pylori 
positive.  
Furthermore, multiplex-urease PCR results were compared with methods used in 
routine, the rapid urease test and histopathological staining. To analyse the efficiency, 
specificity and accuracy of multiplex-urease PCR assay compared with the rapid urease 
test and histopathological staining, Cohen's kappa coefficient value which measures 
inter-rater agreement for categorical items, was calculated for each comparison (Figure 
3.2). If the raters are in complete agreement then κ = 1. The κ value can be interpreted as 
follows; κ <0 ‘’ poor agreement’’, κ = 0.00-0.20 ‘’ slight agreement ‘’, κ = 0.21-0.40 ‘’ 
fair agreement ‘’, κ = 0.41-0.60 ‘’ moderate agreement ‘’, κ = 0.61-0.80 ‘’ substantial 
agreement ‘’, κ = 0.81-1.00 ‘’ almost perfect agreement’’ (Weston et al., 1995). There 
was a substantial agreement between the results of multiplex-urease PCR and the 
histopathological staining. Cohen's kappa coefficient for the comparison of 
histopathological staining and rapid urease test results indicate a moderate agreement. 
There is a fair agreement between the multiplex urease PCR and the rapid urease test 
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results in which the κ is between 0.21-0.40 (Figure 3.2).  Furthermore, the multiplex-
urease PCR can detect H. pylori in some samples that are identified as H. pylori negative 
by the rapid urease test and histopathological staining method. 
 
 
 
 
 
 
 
 
 
Figure 3.1 : Multiplex urease-PCR assay to detect the H. pylori positive and negative 
samples; Lane M, 100 bp ladder- marker (ThermoSCIENTIFIC, Gene Ruler), 
Lane 1 amplification of ureA and ureB genes of H. pylori positive control strain 
G27; between Lane 2 to 5 are from randomly selected patients. Lane 2 is H. 
pylori positive patient sample. Lane 3 to 5 are H. pylori negative samples. 
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Figure 3.2 : Comparison of multiplex urease PCR test results with the rapid urease test 
and histopathological staining. For each comparison Cohen's kappa 
coefficient was used for calculation. 
3.2 Optimization of Multiplex-PCR Conditions for H. pylori Virulence Factors 
H. pylori-specific virulence factors influence the microorganism’s pathogenicity. Many 
multiplex-PCR assays have been reported in the literature to detect the H. pylori-
specific virulence factors that affect clinical outcomes of the infection (Shiota et al., 
2013). However, it is the first reported multiplex-PCR assay that can detect nine H. 
pylori-specific virulence factors in three PCR assay. In this study, it was aimed to 
simultaneously detect the genes that encode various virulence factors in H. pylori, 
namely babA, ureA, ureB, hpaA, cagA, oipA, dupA, napA and vacA, by multiplex- 
PCR. First, we attempt to detect seven H. pylori-specific virulence factors babA, ureA, 
ureB, hpaA, cagA, oipA and vacA by multiplex-PCR assay (Figure 3.3 A). To decrease 
the number of reactions while maximizing the number of detected virulence factors, 
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different primer combinations with different thermal cycling parameters were tested in a 
well-characterized H. pylori strain, G27. However, some of primers for certain 
virulence factors could not be amplified in the same PCR assay. For instance, oipA 
primers could not be amplified with the ureA, ureB and hpaA primers as shown in the 
first reaction of the Figure 3.3 B and different primer combinations were assesed to get 
best results for each virulence factors. While we attempt to optimize multiplex PCR 
assay, two H. pylori virulence factors, napA and dupA, were added to multiplex-PCR 
assay based on recently published data indicating their clinical importance. To find the 
most compatible primer combinations for the detection of virulence factors, different 
primer combinations with different thermalcycling parameters were tested (Figure 3.3 A 
and B). At the end of the optimization studies, nine virulence factors were detected with 
in three PCR assays; five in one, three in one and one in one (Figure 3.3 C). 
Unfortunately, babA virulence factor primers could not be combined with any of the 
other virulence factor primers. 
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Figure 3.3 : Optimization of multiplex-PCR conditions. (A) Representative 
multiplex PCR data for amplification of different combinations of H. 
pylori virulence genes under different PCR conditions; Lane M, 100 bp- 
marker (ThermoSCIENTIFIC, Gene Ruler), Lane 1 (Reaction 1); oipA 
(401bp), vacA (333bp) ureA (244bp), Lane 2 (Reaction 2); ureB (645bp), 
hpaA (534bp), cagA (415bp) and Lane 3 (Reaction 3); babA(832bp). (B) 
Lane M, 100 bp- marker (ThermoSCIENTIFIC, Gene Ruler), Lane 1 
(Reaction 1); ureB (645bp), hpaA (534bp),  oipA (401bp), ureA (244bp), 
Lane 2 (Reaction 2) ureB (645bp), hpaA (534bp),  cagA (415bp) , ureA 
(244bp), Lane 3 (Reaction 3); hpaA (534bp),  vacA (333bp). (C) 
amplification of virulence genes of  H. pylori G27 strain by multiplex 
PCR; Lane M, 100 bp- marker (ThermoSCIENTIFIC, Gene Ruler), Lane 
1 (Reaction 1); ureA (244bp) , ureB (645bp), hpaA (534bp), cagA 
(415bp), napA (384bp), Lane 2 (Reaction 2); dupA (584bp), oipA 
(401bp), vacA (333bp), and Lane 3 (Reaction 3); babA(832bp). 
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3.3 Detection of H. pylori Virulence Factors by Multiplex-PCR 
As a result of optimization studies, it was possible to detect nine H. pylori virulence 
genes within three PCR assays; ureB, hpaA, cagA, napA, ureA in a single reaction, 
dupA, oipA, vacA in a single reaction, and babA in a separate reaction (Figure 3.4 A) by 
using the genomic DNA derived from H. pylori G27 strain. Next, the multiplex-PCR 
was applied to genomic DNA derived from total of 80 H. pylori positive patients; 18 
with ulcer and 62 with gastritis. The images shown in Figure 3.4 B are from a 
representative gel electrophoresis of a multiplex- PCR data of nine H. pylori virulence 
factors. In order to detect H. pylori vacA subtypes in vacA positive gastric specimens, 
four separate PCR assays were performed (Figure 3.3 C) and representative data for 
vacA subtypes in vacA positive patients with ulcer and gastritis are shown in Figure 3.4 
D. Also virulence factors were tested on the negative control biopsy samples taken from 
H. pylori negative patients by multiplex-PCR and there was no PCR product for these 
samples (Figure 3.4 E).  
 
 
 
 
 
 
Figure 3.4 : Multiplex- PCR assay for H. pylori-specific virulence factors; (A) 
amplification of virulence genes of  H. pylori G27 strain by multiplex 
PCR; Lane M, 100 bp- marker (ThermoSCIENTIFIC, Gene Ruler), 
Lane 1 (Reaction 1); ureA (244bp) , ureB (645bp), hpaA (534bp), cagA 
(415bp), napA (384bp), Lane 2 (Reaction 2); dupA (584bp), oipA 
(401bp), vacA (333bp), and Lane 3 (Reaction 3); babA(832bp). 
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Figure 3.4 (continued) :  Multiplex- PCR assay for H. pylori-specific virulence 
factors; (B) Multiplex-PCR application of the biopsy samples taken 
from randomly selected patients with ulcer and gastritis; between Lane 
1 to 6 are representing patients with gastritis or ulcer: Multiplex PCR 
assay results of patient 1 and 2 (gastritis or ulcer) are shown between 
Lane 1 to 3 and Lane 4 to 6, respectively. Reaction 1 (Lane 1 and 4) 
ureA (244bp), ureB (645bp), hpaA (534bp), cagA (415bp), napA 
(384bp), Reaction 2 (Lane 2 and 5); dupA (584bp), oipA (401bp), vacA 
(333bp), and Reaction 3 (Lane 3 and 6); babA(832bp) Multiplex- PCR 
assay for H. pylori-specific virulence factors. (C) PCR inferred results 
of s1/s2 and m1/m2 allelles of vacA gene; Lane 1 (reaction 1); vacA s1 
(259bp), Lane 2 (Reaction 2); vacA s2 (286 bp), Lane 3 (Reaction 3); 
vacA m1 (567 bp), and Lane 4 (Reaction 4) vacA m2(642 bp). (D) PCR 
inferred results of s1/s2 and m1/m2 allelles of vacA gene of randomly 
selected patients with gastritis and ulcer respectively; between Lane 1 to 
3 are representing patients with gastritis (left side) or ulcer (right side): 
Patients with gastritis; Lane 1-3, vacA s1 (259bp), and vacA s2 (286 
bp), patients with ulcer; Lane 1-3, vacA m1 (567 bp), and vacA m2 
(642 bp). 
 
B 
C D 
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Figure 3.4 (continued) : Multiplex- PCR assay for H. pylori-specific virulence factors; 
(E) Multiplex-PCR application of the biopsy samples taken from H. 
pylori negative patients; Lane 1 (Reaction 1); ureA (244bp), ureB 
(645bp), hpaA (534bp), cagA (415bp), napA (384bp), Lane 2 
(Reaction 2); dupA (584bp), oipA (401bp), vacA (333bp), and Lane 3 
(Reaction 3); babA(832bp) Sybr Gold (Invitrogene) was used for the 
gels and gel pictures were taken by using Observable Real Time Gel 
Electrophoresis System (Salubris Technica, Turkey). 
3.4 Correlation between the Virulence Factors in Patients with Gastritis and Ulcer 
H. pylori-specific virulence factors have been found to be associated with increased risk 
of gastric diseases. So far, these virulence factors have been implicated in the 
inflammatory response towards H. pylori by different mechanisms like disturbing tissue 
homeostasis in epithelial cells, host-signaling pathways or stimulating innate immune 
cells (Wroblewski et al., 2010). However, there is not enough information in the 
literature, about the association between the virulence factors in patients with gastritis 
and ulcer. To understand the relationship between various H. pylori-specific virulence 
factors, PCR was applied to genomic DNA derived from total of 80 H. pylori positive 
patients, 18 with ulcer and 62 with gastritis. Nine H. pylori–specific virulence factors; 
CagA, VacA, OipA, BabA, HpaA, NapA, DupA, UreA, UreB were studied to analyse 
the putative link between presence or absence of virulence factors with clinical 
outcomes of diseases associated with H. pylori infection as gastritis and ulcer. 
Association between the detected H. pylori virulence factors were measured by Pearson 
product-moment correlation coefficients that shows the linear relationship between two 
sets of data. The significance was determined by two-tailed test. To reduce the chances 
of obtaining false-positive correlation, Bonferroni correction was applied to Pearson 
product-moment correlation coefficients data. Based on the Pearson product-moment 
E 
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correlation coefficients, there were many negative and positive correlations between 
virulence factors of H. pylori in patients with gastritis and ulcer. When the Bonferroni 
correlation correction was applied to the data, it was shown that there was a significant 
positive correlation between CagA-HpaA (r value = 0,47 and Bonferroni corrected p 
value = 7,01E-03) and NapA-VacA s2 (r value = 0,43 and Bonferroni corrected p value 
=4,61E-02) virulence factors and negative correlation between VacA m1-VacA m2 (r 
value = -0,82 and Bonferroni corrected p value = 2,87E-15) virulence factors in patients 
with gastritis. For the ulcer patients, there was a significant negative correlation between 
VacA m1-VacA m2 virulence factors (r value = -0,84 and Bonferroni corrected p value 
= 0,01) (Figure 3.5 A, B, C and D). All correlations are significant at the level p ≤ 0.05.  
 
 
Figure 3.5 : Pearson product-moment correlation coefficients and Bonferroni 
correction of H. pylori virulence factors correlation data. (A) Pearson 
product-moment correlation coefficients of virulence factors in gastritis. r 
values closer to +1 means there is positive correlation between data and  r 
values closer to -1 means there is negative correlation between data in the 
Pearson product-moment correlation coefficients. Green colored values in the 
Bonferroni correction data show the significant positive correlation between 
data. Red colored values in the Bonferroni correction data show the 
significant negative correlation between data. NA means not applicable. 
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    Figure 3.5 (continued): Pearson product-moment correlation coefficients and 
Bonferroni correction of H. pylori virulence factors correlation data. 
(B) Bonferroni correction of gastritis data (C) Pearson product-
moment correlation coefficients of virulence factors in ulcer. r values 
closer to +1 means there is positive correlation between data and  r 
values closer to -1 means there is negative correlation between data 
in the Pearson product-moment correlation coefficients. Green 
colored values in the Bonferroni correction data show the significant 
correlation between data. Red colored values in the Bonferroni 
correction data show the significant negative correlation between 
data. NA means not applicable. 
 
B 
C 
C 
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Figure 3.5 (continued): Pearson product-moment correlation coefficients and 
Bonferroni correction of H. pylori virulence factors correlation data. 
(D) Bonferroni correction of ulcer data. r values closer to +1 means 
there is positive correlation between data and r values closer to -1 
means there is negative correlation between data in the Pearson 
product-moment correlation coefficients. Green colored values in the 
Bonferroni correction data show the significant correlation between 
data. NA means not applicable. 
3.5 Correlation between The Manifestations of Gastric Disease and Bacterial 
Virulence Factors 
Based on the statistical analysis of multiplex-PCR results which were performed on 18 
patients with ulcer and 62 patients with gastritis, no statistically significant difference 
was detected for the existence of H. pylori cagA, hpaA, oipA, babA, vacAs1, vacAs2, 
vacAm1, vacAm2, ureA, ureB and dupA virulence factor genes among patients with 
gastritis and ulcer (Table 3.1). H. pylori cagA gene was found in 60 % of all isolates; 61 
% of patients with ulcer  and 60 % of patients with gastritis. The H. pylori vacA s1/m2 
genotypes were the most frequent allelic combination of the vacA gene detected both 
among gastritis and ulcer patients. The H. pylori oipA gene prevalence was more 
frequent in ulcer patients than gastritis patients (50 %, 35%). Morover, there was no 
statistically significant difference between the patients with ulcer and gastritis for the 
presence of H. pylori hpaA gene (89% in ulcer patients, 74 % for in gastritis patients), 
D 
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for babA gene (22 % in ulcer patients, 15 % for in gastritis patients), for ureA gene (100 
% in ulcer patients, 94 % for in gastritis patients) and for ureB gene (67 % in ulcer 
patients, 71 % for in gastritis patients). Additionally, no ulcer patients were colonized 
with dupA - positive H. pylori strains, and only 8 % of gastritis patients were colonized 
with dupA positive H. pylori strains. However, interestingly, the prevalence of H. pylori 
napA virulence factor was significantly higher in patients with ulcer than gastritis, which 
is consistent with previous studies (Satin et al., 2000) (Table 3.1). 
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Table 3.1 : Comparison of virulence genes of H. pylori strains isolated from patients 
suffering from gastritis and ulcer. H. pylori strains with napA virulence 
factor gene are found more frequently in patients with ulcer than gastritis. 
Statistical significance was assessed with two-sided Fisher’s exact test. 
  
Strain Type 
 Virulence Genes 
Characteristic 
Ulcer Gastritis 
 n % n % P-value 
cagA 
      
 
Absent 7 39 25 40 1,000 
 
Present 11 61 37 60 
 hpaA 
      
 
Absent 2 11 16 26 0,335 
 
Present 16 89 46 74 
 oipA 
      
 
Absent 9              50 40 65 0,285 
 
Present 9 50 22 35 
 babA 
      
 
Absent 14 78 55 85 0,475 
 
Present 4 22 7 15 
 vacA s1 
      
 
Absent 8 44 31 50 0,791 
 
Present 10 56 31 50 
 vacA s2 
      
 
Absent 15 83 55 89 0,686 
 
Present 3 17 7 11 
 vacA m1 
      
 
Absent 11 61 49 79 0,134 
 
Present 7 39 13 21 
 vacA m2 
      
 
Absent 9 50 17 27 0.090 
 
Present 9 50 45 73 
 ureA 
      
 
Absent 0 0 4            6 0,570 
 
Present 18 100 58 94 
 ureB 
      
 
Absent 6 33 18 29 0,774 
 
Present 12 67 44 71 
 dupA 
      
 
Absent 18 100 57 92 0,582 
 
Present 0 0 5 8 
 napA 
      
 
Absent 8 44 49 79 0,007* 
 Present 10 56 13 21   
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3.6  Correlation between H. pylori Virulence Factors and Involvement of Th1, 
Th17 and Treg in H. pylori-Induced Gastric Diseases 
The association of the Th1, Th17 and Treg cells with H. pylori infection has been 
explained (Larussa et al., 2015), but the effect of H. pylori virulence factor on Th1, 
Th17 and Treg cells in infected patients either gastritis or ulcer has not been clearly 
understood. To determine whether there is an association between H. pylori virulence 
factors and Th1, Th17, and Treg cell responses, the expression levels of, IFN-γ, IL-17, 
and FOXP3 were examined, respectively in human gastric tissue specimens by 
quantitative RT-PCR (qRT-PCR). The significant fold change differences in gene 
expression level of IL-17, IFN-γ and FOXP3 were determined in patients with gastritis 
and ulcer, by calculating 95 % confidence intervals (CIs) of H. pylori negative control 
group. Patients with the confidence interval levels lower than the control group was 
accepted to have normal means with similar IL-17, IFN-γ and FOXP3 gene expression 
levels compared to control group. On the other hand, IL-17, IFN-γ and FOXP3 gene 
expression level higher patient samples with gastritis and ulcer, had higher 95 % 
confidence intervals (CIs) level than the control group (Figure 3.6). 
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Figure 3.6 : Expression levels of IL-17, IFN-γ and FOXP3 in H. pylori infected ulcer 
and gastritis patients. IL-17, IFN-γ and FOXP3 positive samples according 
to the 95 % confidence intervals (CIs) level of control group are shown. 95 
% confidence intervals (CIs) level of control group for IL-17 is 40, 50; 
IFN-γ is 91,58; FOXP3 is 13.768. The horizontal black lines indicate the 
95 % confidence intervals values for each group. Dot plots were drawn 
with R program (N=62 for gastritis, N=18 for ulcer). 
Based on the comparison of 95% confidence interval levels patients’ qRT-PCR results 
with the control group that were negative for H. pylori, ulcer and gastritis patients 
infected with  H. pylori showed mainly to have a Th17 response instead of Th1 and Treg 
response. 88% Th17, 33% Th1 and 5% Treg responses were observed in patients with 
ulcer and 80 % Th17, 35% Th1 and 0% Treg responses were observed in patients with 
gastritis. These results were supporting the association between Th17 response and H. 
pylori infection as previously indicated in the literature (Victoria Serelli et al., 2012)  
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Then we assessed the potential correlation between T cell response and the H. pylori-
specific virulence genes in patients with gastritis and ulcer using Pearson product-
moment correlation coefficients method that is used to measure strength of a linear 
association between two variables in the data (Table 4). Gene expression data of 
cytokines and transcription factors from H. pylori -positive patients were normalized to 
H. pylori –negative patients. For the first time, we detected positive correlation between 
the H. pylori dupA virulence factor and IFN-γ in gastritis patients (r=0.31, N=62, 
p<0.05). Additionally, IL-17 gene expression was shown for the first time to 
significantly positively correlated with the H. pylori babA virulence factor in ulcer 
patients (r=0.74, N=18, p<0.001). These results suggested that correlation between H. 
pylori virulence factors and host immune responses could be used as a diagnostic 
prediction method for gastric diseases. 
Table 3.2 : Correlation between virulence factors and cytokines, transcription factors. A 
Pearson’s correlation between virulence factors and cytokines were 
calculated using R (version 3.1.0, The R Foundation for Statistical 
Computing, Vienna, Austria; http://www.r-project.org). 
 
3.7 Expert-Derived Models for Diagnostic Prediction of Gastric Diseases Using H. 
pylori Virulence Factors and Host Immune Responses 
We created two expert-derived models (Figure 3.7 A and B), which show the 
relationship between the H. pylori specific virulence factors and Th1, Th17 and Treg 
response on the basis of their specific cytokines and transcription factor levels in H. 
Virulence 
Factors/Cytokines 
and Transcription 
Factors 
Gastritis Ulcer 
IL-17 FOXP3 IFN-γ RORγt IL-17 FOXP3 IFN-γ RORγt 
cagA 0,21 -0,05 0,05 -0,02 0,17 -0,31 0,14 -0,34 
hpaA 0,02 -0,02 -0,01 -0,09 0,27 0,04 0,15 0,17 
oipA -0,18 -0,09 0,07 0,06 -0,23 0,27 0,27 0,27 
babA -0,16 0,13 -0,13 -0,08 0,74 -0,11 -0,01 -0,15 
vacA s1 0,13 -0,08 0,17 0,19 0,11 0,16 0,14 -0,16 
vacA s2 0,02 0,09 -0,02 -0,08 -0,01 -0,08 -0,09 0,42 
vacA m1 0,09 0,00 0,09 0,17 0,03 0,36 -0,14 0,28 
vacA m2 -0,13 0,07 -0,06 -0,12 0,08 -0,26 0,22 -0,16 
ureA -0,15 -0,17 -0,01 -0,33 NA NA NA NA 
ureB -0,12 0,02 0,05 -0,09 -0,20 0,10 -0,06 -0,40 
dupA -0,18 0,01 0,31 -0,04 NA NA NA NA 
napA -0,07 0,02 -0,04 0,09 0,05 0,13 -0,38 0,10 
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pylori infected gastritis or ulcer patients. Expert-derived models were built on a 
randomly selected training data consisting of two-thirds of the all dataset and performed 
by determining the most important feature first that can distinguish the ulcer and gastritis 
patients. With the guidance of expert-derived models knowledge of H. pylori virulence 
factors and host T cell response: vacAm1/m2, cagA and ureA presence or absence and 
IL-17, FOXP3 and IFN-γ expression level, it may be possible to predict a patient’s 
clinical outcomes. It is possible to predict and detect significant differences with high 
accuracy between the patients with ulcer and gastritis in the expert-derived model in 
Figure 3.7 A.  
Because of the low ulcer classification accuracy of the first model, (Figure 3.7 A) there 
was a need for additional factors to distinguish ulcer and gastritis patients more 
accurately. An additional factor (IFN-ɣ), which was added to the analysis in a second 
model eventually improved the ulcer classification accuracy from 44% to 61% (Figure 
3.7 B). 
Performance evaluation is made by repeated test set sampling to get comprehensive 
testing set enough to prevent large random fluctuations.  Performance evaluation of the 
models showed that first model (Figure 3.7 A) has mean accuracy of 79% (standard 
deviation: 9%) in gastritis classification, 44% (standard deviation: 16%) in ulcer 
classification. Overall mean classification accuracy of this model was found to be 69% 
(Standard deviation: 8%). On the other hand, performance evaluations of the second 
model (Figure 3.7 B) with repeated test set sampling resulted in a performance of 71% 
(standard deviation: 1%) mean accuracy for gastritis predictions, 61% mean accuracy 
(standard deviation: 17%) for ulcer predictions, which corresponds to a 68% overall 
mean accuracy (standard deviation: 9%). Confusion matrix of models for best 
performing test set samples can be found in Table 3.3.  
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Figure 3.7 : Expert-derived models for diagnostic prediction of gastric diseases using    
H. pylori virulence factors and host immune responses. (A) shows that possible 
relationship prediction between the vacAm1/m2, cagA and ureA and IL-17, 
FOXP3 and patient’s clinical outcomes and (B) shows that the possible 
relationship prediction between vacAm1/m2, cagA and ureA and IL-17, FOXP3 
and IFN-ɣ and patient’s clinical outcomes. 
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Table 3.3 : Confusion matrices for test set predictions. Test set samples with best 
overall classification accuracy was used in calculation of confusion 
matrices. 
Based on Diagnosis/ 
Based on Model   
First Model Second Model 
Actual 
Gastritis 
Actual Ulcer 
Actual 
Gastritis 
Actual Ulcer 
Predicted Gastritis 14 0 13 1 
Predicted Ulcer 2 4 0 6 
 
In the confusion matrix, the actual numbers were the numbers that represent the patients 
with gastritis and ulcer diagnosed based on clinical diagnosis. Additionally, the 
predicted numbers were the number of patients with ulcer or gastritis predicted by the 
models. 
Although, these models may not yet be used for the diagnosis, they may give 
information about the prognosis of the diseases. Gastric malignancies may initiate with 
gastritis and progress to ulcer and at certain cases to gastric cancer. These models help to 
predict this progress. Furthermore, these models will assist to understand the mechanism 
of the gastric diseases with the help of genetic diversity of bacteria and the host immune 
responses and will be advantageous in predicting the clinical presentation of an H. pylori 
infection. 
3.8 The ‘’on/off’’ Functional Status of oipA Gene 
CagA and OipA virulence factors of H. pylori are involved in the ability of bacteria to 
colonize the gastric mucosa layer and to regulate the host environment during the 
development of chronic infection.  In the literature, it has been suggested that the 
presence or absence of cagA gene and functional status of oipA gene have been involved 
in the induction of cellular transformations which plays an important role in the 
development of gastritis (Torres et al., 2014). To investigate the relation between the 
‘’on/off’’ functional status of oipA gene and presence or absence of cagA virulence 
factors on gastritis, PCR and sequencing were performed to 5 patient samples with 
gastritis as a preliminary study. To assess the oipA frame status by the CT repeat 
numbers on the signal peptide coding region, sequencing results of the 5 samples with 
gastritis have been evaluated. The OipA protein coding gene, oipA gene, is regulated by 
a switch (like ‘on’ or ‘off’ patterns) by changing the number of CT dinucleotide repeats 
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in the signal-peptide coding region of this gene. When there is 6, 8 (3+6) or other CT 
dinucleotide repeats that keep the peptide in frame that means oipA gene is “on” status. 
Otherwise, 7 and 5 CT repeats means the status of oipA gene is “off”, which is 
nonfunctional oipA gene (Table 3.4). A PCR-based methodology was applied to detect 
presence of CagA virulence factor in samples.  It was shown that patients infected with 
H. pylori with non-functional oipA gene were also negative for the CagA virulence 
factor. This preliminary data suggest that there is a close link between the H. pylori 
CagA virulence factor and oipA gene status in our patients with gastritis, which is 
consistent with the literature (Torres et al., 2014). Further studies and analysis with a 
larger number of samples are needed to explain this relationship between oipA gene 
status and other H. pylori-specific virulence factors on both gastritis and ulcer. 
Table 3.4 : Sequence of the signal peptide coding region of H. pylori positive gastritis 
patients. Analysis in G27 strain was performed as a positive control. 
Sequence of Signal Peptide Encoding Region of Oip A 
CT 
Number 
Number of  
Patients 
ATG AAA AAA GCT CTC TTA CTA ACT CTC TCT CTC TCG TTC TGG CTC              6 (on) P1 
Met    K       K        A        L       L        L        T       L        S        L        S       F       W       L   
ATG AAA AAA GCT CTC TTA CTA ACT CTC TCT CTC TCT CGT TTT GGC 
TCC                
7 (off) P2 
Met     K      K        A        L       L         L       T      L         S       L        S        R        F       G   
ATG AAA AAA GCT CTC TTA CTA ACT CTC TCT CTC GTT TTG GCT CCA              5 (off) P3 
Met     K       K       A        L       L         L       T       L        S        L        V      L        A   
ATG AAA AAA GCT CTC TTA CTC TCT CTC TCT CTC TCG TTC TGG CTC 
CAC               
8 
(3+6)(on) 
P4 
Met     K       K       A        L        L       L        S        L       S        L        S       F       W       L   
ATG AAA AAA GCT CTC TTA CTC TCT CTC TCT CTC TCG TTC TGG CTC 
CAC                
8 
(3+6)(on) 
P5 
Met     K       K       A        L       L        L        S      L         S        L        S        F     W       L   
ATG AAA AAA GCT CTC TTA CTA ACT CTC TCT CTC TCG TTC TGG CTC               6 (on) G27 
Met     K       K        A       L       L        L       T         L       S         L       S       F       W      L   
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4. DISCUSSION  
The virulence factors of H. pylori, which are known to be directly correlated with the 
extreme degree of genetic heterogenecity in H. pylori genome, play a pivotal role in 
determining the outcome of H. pylori infection. The immune response of the host 
including T cell activation has also been the subject of recent studies, together with 
specific virulence factors of H. pylori (Kaebisch et al., 2014). 
Multiplex-PCR based genotyping systems have initially been developed to detect the H. 
pylori-specific virulence factors. However, these assays were not sufficient to detect 
many H. pylori-specific virulence factors that are thought to be associated with bacterial 
pathogenesis and increase the risk for developing severe clinical manifestations, in the 
same PCR assay. In this study, a genotyping system-based multiplex-PCR assay was 
developed to detect nine potential virulence genes (vacA, cagA, oipA, babA, hpaA, dupA, 
napA, ureA, ureB) in three PCR assays directly from human gastric biopsies. This assay 
is able to detect both the presence and absence of H. pylori by ureA and ureB genes, and 
identify the leading disease-associated virulence genes of H. pylori strains isolated from 
patients. Moreover, this PCR assay helps to better understand the relationship between 
the virulence factors and different clinical forms of gastric lesions and the pathogenesis 
of each of these factors. 
Multiplex-PCR assay results do not indicate any correlation between the H. pylori genes 
vacA, cagA, oipA, babA, hpaA, dupA, ureA, ureB and H. pylori-related gastritis and ulcer 
diseases. However, a statistically significant relationship (p=0.007) between napA gene 
and H. pylori-associated ulcer disease were identified, as reported previously (Rautelin 
et al., 1993). 
Virulence factors of H. pylori are one of the major determinants of H. pylori-related 
infection and disease course. Association between the virulence factors can be another 
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determinant of H. pylori-related gastric diseases. Multiplex-PCR assay results indicate a 
positive correlation between the CagA-HpaA and NapA-VacA s2 virulence factors for 
patients with gastritis and a negative correlation between the VacA m1-VacA m2 
virulence factors for patients with gastritis and ulcer. Negative correlation between the 
VacA m1-VacA m2 for both patients with gastritis and ulcer can be explained by the 
allelic variation in the mid-region of the vacA gene sequence. Variations in vacA gene 
sequences are mainly found restricted to three genetic regions: the signal sequence 
region (s-region), mid-region (m-region) and the recently identified intermediate-region 
(i-region). Also, two types of allelic variations in the s-region and m-region are classified 
as s1 or s2 and m1 or m2. Isolated H. pylori strains include one of the allele of s-region 
(s1or s2) and one of the allele of m-region (m1 or m2). Adhesion to the gastric mucosa 
is a critical initial step in the H. pylori pathogenesis. The virulence factors play role in 
the bacterial adhesion. Positive correlation between CagA-HpaA and NapA-VacA s2 
may be explained by the role of these virulence factors on the bacterial adhesion and 
also colonization on the gastric mucosa. Experimental results of this study suggest that 
correlation between virulence factors would be a useful marker to identify patients who 
are at higher risk for specific H. pylori-related gastric diseases. However, a large sample 
size would provide a more precise estimate of the association between these virulence 
factors and H. pylori-related gastric diseases.  
There are many different tests available to identify H. pylori, each of which has certain 
advantages and disadvantages. However, due to poor sensitivity or specificity, none of 
them can be considered as gold standard. Rapid urease test and pathological staining are 
the most useful methods in the clinical practice to detect H. pylori. In this study, 
multiplex urease PCR assay was developed to detect ureA and ureB virulence genes of 
H. pylori. Comparison of the results of the rapid urease test with histopathological 
staining and the multiplex urease PCR indicated that detection rate of H. pylori with 
multiplex urease PCR and histopathological staining is higher than the rapid urease test. 
The possible reason for the lack of sensitivity of rapid urease test might be the region of 
biopsy specimens that is taken to be only from the antrum part of the stomach where the 
most of the bacterial colonization can be seen. However, localization of H. pylori 
colonies in patients can vary as being only in antrum, only in corpus or in both antrum 
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and the corpus part of the stomach. In the multiplex urease PCR and histopathological 
staining method two biopsy specimens, one from antrum and one from corpus part of 
stomach are taken to increase the detection rate of H. pylori. Additionally, we identified 
that sensivity of multiplex urease PCR assay was higher than the histopathological 
staining in this study. The reason for this may be because PCR may detect the DNA of 
the bacteria that has just began to colonize and the histopathological staining may not 
detect this newly colonized bacteria. Using the combinations of rapid urease test, 
histopathological staining and multiplex urease PCR assay, may provide quite 
satisfactory results in the diagnosis of H. pylori infection. 
 The type of host immune response, particularly driven by T cells, is crucial for the 
outcome of H. pylori infection in humans. Given the increasing number of reports, 
correlations between the characteristics of the T helper cell responses of Th1, Th17, and 
Treg cells and virulence factors are great interest in determining the outcomes of H. 
pylori infections (Aujla et al., 2007; Larussa et al., 2015). In previous studies, it was 
shown that Th1 cells contributed to inflammation and participated in the pathogenesis of 
H. pylori infection (Shi et al., 2010). The role of Th17 in host protection against gram-
negative bacteria has also been shown (Smythies et al., 2000). However, the role of 
Th17 has not been clearly explicated. In this study, we characterized the cell responses 
of T helper cells, particularly Th1 and Th17, in H. pylori positive clinical isolates 
obtained from patients with gastritis and ulcer. One of the most prominent outcomes of 
the study was the identification of a higher Th17 cell response compared to Th1 
response against H. pylori infection in patients with gastritis and ulcer. This finding has 
been shown previously in mice models (Aujla et al., 2007). To the best of our 
knowledge, this is the first time that a higher Th17 cell response compared to Th1 
response to H. pylori infection has been shown in clinical samples. A possible reason for 
this outcome is that, Th17 cells may play a role in the pathogenesis of H. pylori infection 
by promoting the mucosal inflammation and thus contributing to bacterial colonization. 
Also Th1 cells causes mucosal inflammation in H. pylori infection, but our results 
suggested that Th17 cell responses may be induced earlier than Th1 cell responses in H. 
pylori infected ulcer and gastritis patients. To obtain more definitive results about the 
induction of Th17 cell responses in H. pylori infected ulcer and gastritis patients, further 
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studies including larger number of clinical samples should be done. Moreover, ELISA-
based assays for quantifying the levels of secreted proteins can be performed. 
The H. pylori specific virulence factors are important for the pathogenesis of this 
organism. These virulence factors facilitate the survival of the bacterium and modifiy the 
immune response. In support of this, we found a correlation between dupA positive 
strains and IFN-ɣ (Th1-specific cytokine) expression levels in patients with gastritis. 
Our results confirmed a previous study that suggests dupA causing gastric inflammation 
and pathology either directly or indirectly over action upon infiltrating leukocytes rather 
than upon epithelial cells. It was also referred in the study that dupA positive H. pylori 
strains increase the risk of disease by stimulating a more definite Th1 response (Hussein 
et al., 2010). 
Virulence factor babA helps bacteria to adhere to the fucosylated Lewis b antigen on the 
surface of the gastric epithelial cells. H. pylori adheres to the host and secretes effector 
molecules that can change function and viability of gastric epithelial cells. The 
production of various cytokines, gastric inflammation, and epithelial cell damage is 
enhanced by these changes. Also recent studies have indicated that there is severe 
mucosal injury in patients infected with babA positive H. pylori strains (Ohno et al., 
2011). Our data showed, for the first time, a relationship between babA positivity and 
interleukin-17 (IL-17) expression levels in patients with ulcer. 
In this present study, it was identified that there are significant correlations between the 
virulence factors of H. pylori, responses of T cells (Th1, Th17, Treg) and clinical 
outcomes of H. pylori infections, and these eventually helped evolution of expert-
derived models. Initially, first model was developed using the strategy outlined in the 
method section. To improve the low classification accuracy of ulcer disease in this 
model, we added additional factors to the model. The addition of IFN-ɣ to the second 
model (model 2) eventually improved the classification accuracy of ulcer from 44% to 
61% with a cost of only one misclassified gastritis patient. On overall, to our knowledge, 
this is the first report of expert-derived models, which points out the relationship 
between H. pylori virulence factors and host immune responses. Despite a need to 
improve the accuracy, these models could contribute to the prediction of clinical 
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outcomes of a patients infected with H. pylori by screening the patient’s H. pylori vacA 
m1/m2, ureA and cagA status and IL-17, FOXP3 and IFN-ɣ expression levels. 
OipA is one of the H. pylori specific outer membrane proteins that takes an important 
role in bacterial pathogenecity such as virulence (Torres et al., 2014). Expression of 
oipA gene is regulated by CT dinucleotide repeats in the 5’ signal coding regions of the 
gene. DNA sequence analysis and PCR based findings suggested an association between 
the on status of oipA and presence of the CagA virulence factor on gastritis. Oip A 
virulence factor has an important role in the bacterial adhesion and CagA is encoded by 
the cag Pathogenecity Island that encodes for type IV secretion system used to inject 
CagA virulence factor into the target cell upon bacterial attachment. Morover, it has 
been known that Cag A positive strains are associated with severe clinical outcomes. 
The association between cagA and oipA may be explained by their role in the bacterial 
attachment to the gastric layer, since it is known that adherent H. pylori strains are more 
prone to elimination by the host immune system. Correlation between the Cag A 
virulence factors and functional status of oipA may present a putative marker for gastric 
diseases.To obtain more definitive data, this study has to be applied to a larger sample 
set with gastritis and ulcer.  
In conclusion, these data support the hypothesis that the relationship between the H. 
pylori specific virulence factors and Th1, Th17 and Treg cells have an important role in 
the progression of H. pylori driven pathology. A better understanding of the effects of 
virulence factors on T cell responses may help to estimate the clinical outcomes of H. 
pylori infection and develop therapies to prevent risk for gastric cancer development. 
Correlation between the virulence factors may be additional criteria that help to estimate 
the H. pylori related gastric diseases. 
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APPENDIX A 
 
 
Laminar Air Flow Cabinets FASTER BH-EN 2003 
Precisa BJ 610C 
Pipettes 10 µL, 20 µL , 100 μl, 200 µL, 1000 μl Socorex 
                                                            And 10 µL, 100 μl, 1000 μl Biohit 
Centrifuge Beckman Coulter Allegra 
TM 
25R Centrifuge 
                                                           Scanspeed 1730 R  
                                                           Labogene Scanspeed mini 
Gel Documentation System UVI PhotoMW Version 99.05 for Windows 
ChemiDoc™ MP Imaging System 
ORTE Observable Real Time Electrophoresisi, 
SALUBRIS 
SpeedMill PLUS Homogenizator  Analytikjena 
Thermal cycler Applied Biosystems  
Vortex Mixer Uzusio VTX-3000L, LMS 
Quick spin LMS 
Ice Machine Scotsman AF10 
Freezers Altus (+4 ᵒC) 
                                                        Siemens (-20 ᵒC) 
                                                        Haier (-80 ᵒC) 
Power Supply BIO-RAD 
Centrifuge tubes                               Interlab 
Eppendorf tubes                               Interlab 
Nanodrop 2000                    Thermo Scientific 
Examination gloves  Beybi 
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APPENDIX B 
 
Agarose  Appli Chem 
Glacial Acetic Acid Appli Chem 
dNTP Thermo 
EDTA Appli Chem 
SYBR Gold Fermentas 
Tris Base Sigma-Aldrich 
RNA Stabilization Solution Sigma-Aldrich 
Power SYBR Green PCR Master Mix            Applied Biosystems 
5x FIREPol® Master Mix Ready to Load       Solis Biodyne 
Quick g-DNA
TM
 130                               Zymo Research 
Innu Prep RNA Isolation Kit                          Analytikjena 
cDNA Synthesis Kit                                        Applied Biosystems 
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APPENDIX C 
TAE (Tris-Acetate-EDTA) Buffer (50X) 
Tris base                         242 g 
Glacial Acetic Acid                         57.1 ml 
EDTA                            100 ml (0.5 M, pH 8.0) 
Add ddH2O to 1 liter and adjust the pH to 8.0 
Mini Agarose Gel (1%)  
Agarose                          0.5 g 
TAE buffer (1X)                          50 mL 
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